<SEC-DOCUMENT>0000950103-26-008330.txt : 20260602
<SEC-HEADER>0000950103-26-008330.hdr.sgml : 20260602
<ACCEPTANCE-DATETIME>20260602162529
ACCESSION NUMBER:		0000950103-26-008330
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20260602
DATE AS OF CHANGE:		20260602

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BARCLAYS BANK PLC
		CENTRAL INDEX KEY:			0000312070
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287303
		FILM NUMBER:		261056425

	BUSINESS ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP
		BUSINESS PHONE:		0044-20-3555-4619

	MAIL ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK PLC /ENG/
		DATE OF NAME CHANGE:	19990402

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK INTERNATIONAL LTD
		DATE OF NAME CHANGE:	19850313
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp247733_424b2-8889wfps.htm
<DESCRIPTION>FORM 424B2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="width: 53%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">PRICING SUPPLEMENT dated May 29, 2026</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">(To the Prospectus dated May 15, 2025,</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">the Prospectus Supplement dated May 15, 2025
and</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">the Product Supplement No. WF-1 dated May
20, 2025)</P></TD>
    <TD STYLE="width: 47%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Filed Pursuant to Rule 424(b)(2)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Registration Statement No. 333-287303</P></TD></TR>
  <TR>
    <TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="image_001.jpg" ALT="barclays PLC logo" STYLE="height: 42px; width: 179px"></FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EDEFEE">
    <TD STYLE="width: 100%">
    <P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Barclays Bank PLC</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left; color: #BB0826">Global Medium-Term Notes, Series
A</P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #D5D9D8">
    <TD>
    <P STYLE="color: #BB0826; font: bold 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">$986,000 Market Linked Securities&mdash;Upside
Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P>
    <P STYLE="color: #BB0826; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Principal at Risk Securities
Linked to the Class B Common Stock of Berkshire Hathaway Inc. due December 4, 2028</P></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Verdana, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="background-color: rgb(104,143,207); text-align: center; color: white"><FONT STYLE="font-family: Wingdings; color: white">n</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 6pt; background-color: rgb(104,143,207); text-align: justify; text-indent: 0in; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: white">Linked to the Class B common stock of Berkshire Hathaway Inc. (the &ldquo;<U>Underlying Stock</U>&rdquo;)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="background-color: rgb(104,143,207); text-align: center; color: white"><FONT STYLE="font-family: Wingdings; color: white">n</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 6pt; background-color: rgb(104,143,207); text-align: justify; text-indent: 0in; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: white">Unlike ordinary debt securities, the securities do not pay interest or repay a fixed amount of principal at maturity. Instead, the securities provide for a maturity payment amount that may be greater than, equal to or less than the principal amount of the securities, depending on the performance of the Underlying Stock from the starting price to the ending price. The maturity payment amount will reflect the following terms:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="background-color: rgb(104,143,207); text-align: center; color: white; width: 3%">&nbsp;</TD>
    <TD STYLE="padding-right: 6pt; background-color: rgb(104,143,207); text-align: justify; color: white; width: 3%"><FONT STYLE="font-family: Wingdings; color: white">n</FONT></TD>
    <TD STYLE="padding-right: 6pt; background-color: rgb(104,143,207); text-align: justify; color: white; width: 94%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: white">If the price of the Underlying Stock increases, you will receive the principal amount plus a positive return equal to 100% of the percentage increase in the price of the Underlying Stock from the starting price to the ending price, subject to a maximum upside return at maturity of 22.70% of the principal amount. As a result of the maximum upside return, the maximum maturity payment amount will be $1,227.00 per security if the Underlying Stock appreciates.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="background-color: rgb(104,143,207); text-align: center; color: white">&nbsp;</TD>
    <TD STYLE="padding-right: 6pt; background-color: rgb(104,143,207); text-align: justify; color: white"><FONT STYLE="font-family: Wingdings; color: white">n</FONT></TD>
    <TD STYLE="padding-right: 6pt; background-color: rgb(104,143,207); text-align: justify; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: white">If the price of the Underlying Stock decreases but the decrease is not more than 15%, you will receive the principal amount <I>plus</I> a positive return equal to the absolute value of the percentage decline in the price of the Underlying Stock from the starting price to the ending price, which will be effectively capped at a positive return of 15%.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="background-color: rgb(104,143,207); text-align: center; color: white">&nbsp;</TD>
    <TD STYLE="padding-right: 6pt; background-color: rgb(104,143,207); text-align: justify; color: white"><FONT STYLE="font-family: Wingdings; color: white">n</FONT></TD>
    <TD STYLE="padding-right: 6pt; background-color: rgb(104,143,207); text-align: justify; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: white">If the price of the Underlying Stock decreases by more than 15%, you will receive less than the principal amount and will have 1-to-1 downside exposure to the decrease in the price of the Underlying Stock in excess of 15%.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="background-color: rgb(104,143,207); text-align: center; color: white"><FONT STYLE="font-family: Wingdings; color: white">n</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 6pt; background-color: rgb(104,143,207); text-align: justify; text-indent: 0in; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: white">Investors may lose up to 85% of the principal amount.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="background-color: rgb(104,143,207); text-align: center; color: white"><FONT STYLE="font-family: Wingdings; color: white">n</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 6pt; background-color: rgb(104,143,207); text-align: justify; text-indent: 0in; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: white">Any payment on the securities, including any repayment of principal, is subject to the creditworthiness of Barclays Bank PLC and is not guaranteed by any third party. If Barclays Bank PLC were to default on its payment obligations or become subject to the exercise of any U.K. Bail-in Power (as described on page PS-6 of this pricing supplement) by the relevant U.K. resolution authority, you might not receive any amounts owed to you under the securities. See &ldquo;Selected Risk Considerations&rdquo; and &ldquo;Consent to U.K. Bail-in Power&rdquo; in this pricing supplement and &ldquo;Risk Factors&rdquo; in the accompanying prospectus supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="background-color: rgb(104,143,207); text-align: center; color: white"><FONT STYLE="font-family: Wingdings; color: white">n</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 6pt; background-color: rgb(104,143,207); text-align: justify; text-indent: 0in; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: white">No periodic interest payments or dividends</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="background-color: rgb(104,143,207); text-align: center; color: white"><FONT STYLE="font-family: Wingdings; color: white">n</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 6pt; background-color: rgb(104,143,207); text-align: justify; text-indent: 0in; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: white">No exchange listing; designed to be held to maturity</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">See &ldquo;Additional Information about the
Issuer and the Securities&rdquo; on page PS-4 of this pricing supplement. The securities will have the terms specified in the prospectus
dated May 15, 2025, the prospectus supplement dated May 15, 2025 and the product supplement no. WF-1 dated May 20, 2025, as supplemented
or superseded by this pricing supplement.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The securities have complex features and
investing in the securities involves risks not associated with an investment in conventional debt securities. See &ldquo;Selected Risk
Considerations&rdquo; on page PS-10 herein, &ldquo;Risk Factors&rdquo; beginning on page PS-3 of the product supplement and &ldquo;Risk
Factors&rdquo; beginning on page S-9 of the prospectus supplement.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The securities constitute our unsecured and
unsubordinated obligations. The securities are not deposit liabilities of Barclays Bank PLC and are not covered by the U.K. Financial
Services Compensation Scheme or insured by the U.S. Federal Deposit Insurance Corporation or any other governmental agency or deposit
insurance agency of the United States, the United Kingdom or any other jurisdiction.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Neither the U.S. Securities and Exchange
Commission (the &ldquo;<U>SEC</U>&rdquo;) nor any state securities commission has approved or disapproved of these securities or determined
that this pricing supplement is truthful or complete. Any representation to the contrary is a criminal offense.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">We may use this pricing supplement in the
initial sale of the securities. In addition, Barclays Capital Inc. or any other of our affiliates may use this pricing supplement in
market resale transactions in any of the securities after their initial sale. Unless we or our agent informs you otherwise in the confirmation
of sale, this pricing supplement is being used in a market resale transaction.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Notwithstanding and to the exclusion of any
other term of the securities or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial
owner of the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial
owner of the securities acknowledges, accepts, agrees to be bound by, and consents to the exercise of, any U.K. Bail-in Power by the
relevant U.K. resolution authority. See &ldquo;Consent to U.K. Bail-in Power&rdquo; on page PS-6 of this pricing supplement.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Verdana, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 21%; font-family: Arial, Helvetica, Sans-Serif; text-align: justify; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 27%; border-bottom: Black 1pt solid; font-family: Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Original Offering Price<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="width: 26%; border-bottom: Black 1pt solid; font-family: Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Agent Discount<SUP>(2), (3)</SUP></B></FONT></TD>
    <TD STYLE="width: 26%; border-bottom: Black 1pt solid; font-family: Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proceeds to Barclays Bank PLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per Security</B></FONT></TD>
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$25.75</FONT></TD>
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$974.25</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$986,000.00</FONT></TD>
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$25,389.50</FONT></TD>
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$960,610.50</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><SUP>(1)</SUP></TD><TD STYLE="text-align: justify">Our estimated value of the securities on the pricing date, based on our internal pricing models, is $963.50
per security. The estimated value is less than the original offering price of the securities. See &ldquo;Additional Information Regarding
Our Estimated Value of the Securities&rdquo; on page PS-5 of this pricing supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><SUP>(2)</SUP></TD><TD STYLE="text-align: justify">Wells Fargo Securities, LLC (&ldquo;<U>WFS</U>&rdquo;) and Barclays Capital Inc. are the agents for the
distribution of the securities and are acting as principal. The agent will receive an underwriting discount of $25.75 per security. Barclays
Capital Inc. will sell the securities to WFS at the original offering price of the securities less a concession of $25.75 per security.
WFS may provide dealers, which may include Wells Fargo Advisors (&ldquo;<U>WFA</U>&rdquo;) (the trade name of the retail brokerage business
of WFS&rsquo;s affiliates, Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial Network, LLC), with a selling concession
of $20.00 per security. In addition to the concession allowed to WFA, WFS may pay $0.75 per security of the agent&rsquo;s discount to
WFA as a distribution expense fee for each security sold by WFA. See &ldquo;Terms of the Securities&mdash;Supplemental Plan of Distribution&rdquo;
in this pricing supplement for further information.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><SUP>(3)</SUP></TD><TD STYLE="text-align: justify">In respect of certain securities sold in this offering, Barclays Capital Inc. may pay a fee of up to $3.00
per security to selected securities dealers in consideration for marketing and other services in connection with the distribution of the
securities to other securities dealers.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font: bold 12pt Arial, Helvetica, Sans-Serif; text-align: justify">Wells Fargo Securities</TD>
    <TD STYLE="width: 50%; font: bold 12pt Arial, Helvetica, Sans-Serif; text-align: right">Barclays Capital Inc.</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: bold 14pt Arial, Helvetica, Sans-Serif; color: #BB0826; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Class B Common Stock of Berkshire Hathaway Inc. due December 4, 2028</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Terms
of the Securities</P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR>
    <TD STYLE="width: 21%; border: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Issuer:</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 79%; font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Barclays Bank PLC</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Market Measure<SUP>1</SUP>:</B></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The Class B common stock of Berkshire Hathaway Inc. (Bloomberg ticker symbol &ldquo;BRK.B UN&lt;Equity&gt;&rdquo;) (the &ldquo;<U>Underlying Stock</U>&rdquo;). <FONT STYLE="background-color: white">We refer to the issuer of the Underlying Stock as the &ldquo;<U>Underlying Stock Issuer.</U>&rdquo;</FONT></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Pricing Date:</B></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">May 29, 2026</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Issue Date:</B></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">June 3, 2026</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Calculation Day<SUP>2</SUP>:</B></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">November 29, 2028</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Stated Maturity Date<SUP>2</SUP>:</B></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">December 4, 2028</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Principal Amount:</B></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">$1,000 per security. References in this pricing supplement to a &ldquo;<U>security</U>&rdquo; are to a security with a principal amount of $1,000.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Maturity Payment Amount: </B></FONT></TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you will be entitled
    to receive a cash payment per security in U.S. dollars equal to the maturity payment amount. The &ldquo;<U>maturity payment amount</U>&rdquo;
    per security will equal:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&#183;&#9;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">if
    the ending price is greater than the starting price: $1,000 <I>plus</I> the lesser of:</FONT></P>
    <P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$1,000
    &times; stock return &times; upside participation rate; and</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
    maximum upside return;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>
    <P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&#183;&#9;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">if
    the ending price is less than or equal to the starting price, but greater than or equal to the threshold price: </FONT></P>
    <P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.35pt; text-align: left; text-indent: 0in">$1,000 + ($1,000 &times;
    absolute value return); or</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.35pt; text-align: left; text-indent: 0in">&nbsp;</P>
    <P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&#183;&#9;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">if
    the ending price is less than the threshold price: </FONT></P>
    <P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">$1,000 + [$1,000 &times; (stock return + buffer amount)]</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If the ending price is less than the threshold
price, you will lose up to 85% of the principal amount of your securities at maturity. Any payment on the securities, including any repayment
of principal, is subject to the creditworthiness of Barclays Bank PLC and is not guaranteed by any third party. If Barclays Bank PLC
were to default on its payment obligations or become subject to the exercise of any U.K. Bail-in Power by the relevant U.K. resolution
authority, you might not receive any amounts owed to you under the securities.</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Maximum Upside Return:</B></FONT></TD>
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The &ldquo;<U>maximum upside return</U>&rdquo; is 22.70% of the principal amount ($227.00 per security). As a result of the maximum upside return, the maximum maturity payment amount if the Underlying Stock appreciates will be $1,227.00 per security.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Upside Participation Rate:</B></FONT></TD>
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">100%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Threshold Price:</B></FONT></TD>
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">$403.308, which is equal to 85% of the starting price</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Buffer Amount: </B></FONT></TD>
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">15%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Stock Return:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The &ldquo;stock return&rdquo; is the percentage
    change from the starting price to the ending price, measured as follows:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><U>ending price &ndash; starting price</U></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;starting price</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Absolute Value Return:</B></FONT></TD>
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The &ldquo;absolute value return&rdquo; is the absolute value of the stock return. For example, a -5% stock return will result in a +5% absolute value return.</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Class B Common Stock of Berkshire Hathaway Inc. due December 4, 2028</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 21%; border: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Starting Price:</B></FONT></TD>
    <TD STYLE="width: 79%; font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">$474.48, which is the stock closing price of the Underlying Stock on the pricing date</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Ending Price:</B></FONT></TD>
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The &ldquo;<U>ending price</U>&rdquo; will be the stock closing price of the Underlying Stock on the calculation day.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Stock Closing Price<SUP>1</SUP>:</B></FONT></TD>
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<U>Stock closing price</U>&rdquo; has the meaning set forth under &ldquo;General Terms of the Securities&mdash;Certain Terms for Securities Linked to an Underlying Stock&mdash;Certain Definitions&rdquo; in the product supplement. The stock closing price of the Underlying Stock is subject to adjustment through the adjustment factor as described in the product supplement.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Additional Terms:</B></FONT></TD>
    <TD STYLE="vertical-align: top; font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Terms used in this pricing supplement, but not defined herein, will have the meanings ascribed to them in the product supplement, <I>provided</I> that terms used in this pricing supplement, but not defined herein or in the product supplement, will have the meanings ascribed to them in the prospectus supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Calculation Agent:</B></FONT></TD>
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Barclays Bank PLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Tax Considerations:</B></FONT></TD>
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">For a discussion of the tax considerations relating to ownership and disposition of the securities, see &ldquo;Tax Considerations.&rdquo;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Denominations:</B></FONT></TD>
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">$1,000 and any integral multiple of $1,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD STYLE="font-family: Georgia, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">06749GZZ3 / US06749GZZ35</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2; font-family: Georgia, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Supplemental Plan of Distribution:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Wells Fargo Securities, LLC (&ldquo;<U>WFS</U>&rdquo;)
    and Barclays Capital Inc. will act as agents for the securities. The agent will receive an underwriting discount of $25.75 per security.
    Barclays Capital Inc. will sell the securities to WFS at the original offering price of the securities less a concession of $25.75 per
    security. WFS may provide dealers, which may include Wells Fargo Advisors (&ldquo;<U>WFA</U>&rdquo;) (the trade name of the retail brokerage
    business of WFS&rsquo;s affiliates, Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial Network, LLC), with a selling
    concession of $20.00 per security. In addition to the concession allowed to WFA, WFS may pay $0.75 per security of the agent&rsquo;s discount
    to WFA as a distribution expense fee for each security sold by WFA.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, in respect of certain securities
    sold in this offering, Barclays may pay a fee of up to $3.00 per security to selected securities dealers in consideration for marketing
    and other services in connection with the distribution of the securities to other securities dealers.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Barclays Bank PLC or its affiliate will enter
into swap agreements or related hedge transactions with one of its other affiliates or unaffiliated counterparties in connection with
the sale of the securities. If WFS, Barclays Capital Inc. or an affiliate of either agent participating as a dealer in the distribution
of the securities conducts hedging activities for Barclays Bank PLC in connection with the securities, such agent or participating dealer
will expect to realize a projected profit from such hedging activities, and this projected profit will be in addition to any discount,
concession or fee received in connection with the sale of the securities to you. This additional projected profit may create a further
incentive for the agents or participating dealers to sell the securities to you.</P></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>


<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>1</SUP> In the case of certain corporate
events related to the Underlying Stock, the calculation agent may adjust the adjustment factor of the Underlying Stock if the calculation
agent determines that the event has a diluting or concentrative effect on the theoretical value of the shares of the Underlying Stock.
Upon the occurrence of certain reorganization events with respect to the Underlying Stock, the calculation agent will make adjustments
to reflect the amount and type of property deliverable for one share of the Underlying Stock as a result of that reorganization event.
The Underlying Stock may be replaced with another stock selected by the calculation agent upon the occurrence of certain replacement stock
events. For more information, see &ldquo;General Terms of the Securities&mdash;Certain Terms for Securities Linked to an Underlying Stock&mdash;Adjustment
Events&rdquo; in the accompanying product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>2 </SUP>If the calculation day is not a trading
day, the calculation day will be postponed to the next succeeding trading day. The calculation day will also be postponed if a market
disruption event occurs on the calculation day as described under &ldquo;General Terms of the Securities&mdash;Consequences of a Market
Disruption Event; Postponement of a Calculation Day&mdash;Securities Linked to a Single Market Measure&rdquo; in the accompanying product
supplement. In addition, the stated maturity date will be postponed if that day is not a business day or if the calculation day is postponed
as described under &ldquo;General Terms of the Securities&mdash;Payment Dates&rdquo; in the accompanying product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Class B Common Stock of Berkshire Hathaway Inc. due December 4, 2028</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Additional
Information about the Issuer and the Securities</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should read this pricing supplement together
with the prospectus dated May 15, 2025, as supplemented by the prospectus supplement dated May 15, 2025 relating to our Global Medium-Term
Notes, Series A, of which these securities are a part and the product supplement no. WF-1 dated May 20, 2025. This pricing supplement,
together with the documents listed below, contains the terms of the securities and supersedes all prior or contemporaneous oral statements
as well as any other written materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for
implementation, sample structures, brochures or other educational materials of ours. You should carefully consider, among other things,
the matters set forth under &ldquo;Risk Factors&rdquo; in the prospectus supplement and &ldquo;Selected Risk Considerations&rdquo; in
this pricing supplement, as the securities involve risks not associated with conventional debt securities. We urge you to consult your
investment, legal, tax, accounting and other advisors before you invest in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent the information or terms in this
pricing supplement are different from or inconsistent with the information or terms in the prospectus, prospectus supplement or product
supplement, the information and terms in this pricing supplement will control. To the extent the information or terms in the product supplement
are different from or inconsistent with the information or terms in the prospectus or prospectus supplement, the information and terms
in the product supplement will control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may access these documents on the SEC website
at www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prospectus dated May 15, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm">http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm</A></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prospectus Supplement dated May 15, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm">http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm</A></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Product Supplement No. WF-1 dated May 20, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006260/dp229046_424b2-wf1.htm">http://www.sec.gov/Archives/edgar/data/312070/000095010325006260/dp229046_424b2-wf1.htm</A></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our SEC file number is 1-10257. As used in this
pricing supplement, &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; refer to Barclays Bank PLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Class B Common Stock of Berkshire Hathaway Inc. due December 4, 2028</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Additional
Information Regarding Our Estimated Value of the Securities</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our internal pricing models take into account
a number of variables and are based on a number of subjective assumptions, which may or may not materialize, typically including volatility,
interest rates and our internal funding rates. Our internal funding rates (which are our internally published borrowing rates based on
variables, such as market benchmarks, our appetite for borrowing and our existing obligations coming to maturity) may vary from the levels
at which our benchmark debt securities trade in the secondary market. Our estimated value on the pricing date is based on our internal
funding rates. Our estimated value of the securities might be lower if such valuation were based on the levels at which our benchmark
debt securities trade in the secondary market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our estimated value of the securities on the pricing
date is less than the original offering price of the securities. The difference between the original offering price of the securities
and our estimated value of the securities results from several factors, including any sales commissions to be paid to Barclays Capital
Inc. or another affiliate of ours, any selling concessions, discounts, commissions or fees to be allowed or paid to non-affiliated intermediaries,
the estimated profit that we or any of our affiliates expect to earn in connection with structuring the securities, the estimated cost
that we may incur in hedging our obligations under the securities, and estimated development and other costs that we may incur in connection
with the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our estimated value on the pricing date is not
a prediction of the price at which the securities may trade in the secondary market, nor will it be the price at which Barclays Capital
Inc. may buy or sell the securities in the secondary market. Subject to normal market and funding conditions, Barclays Capital Inc. or
another affiliate of ours intends to offer to purchase the securities in the secondary market but it is not obligated to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assuming that all relevant factors remain constant
after the pricing date, the price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market, if
any, and the value that we may initially use for customer account statements, if we provide any customer account statements at all, may
exceed our estimated value on the pricing date for a temporary period expected to be approximately three months after the initial issue
date of the securities because, in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost
of hedging our obligations under the securities and other costs in connection with the securities that we will no longer expect to incur
over the term of the securities. We made such discretionary election and determined this temporary reimbursement period on the basis of
a number of factors, which may include the tenor of the securities and/or any agreement we may have with the distributors of the securities.
The amount of our estimated costs that we effectively reimburse to investors in this way may not be allocated ratably throughout the reimbursement
period, and we may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the initial issue
date of the securities based on changes in market conditions and other factors that cannot be predicted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We urge you to read the &ldquo;Selected Risk
Considerations&rdquo; beginning on page PS-10 of this pricing supplement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Class B Common Stock of Berkshire Hathaway Inc. due December 4, 2028</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Consent
to U.K. Bail-in Power</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Notwithstanding and to the exclusion of any
other term of the securities or any other agreements, arrangements or understandings between us and any holder or beneficial owner of
the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial owner
of the securities acknowledges, accepts, agrees to be bound by, and consents to the exercise of, any U.K. Bail-in Power by the relevant
U.K. resolution authority.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the U.K. Banking Act 2009, as amended, the
relevant U.K. resolution authority may exercise a U.K. Bail-in Power in circumstances in which the relevant U.K. resolution authority
is satisfied that the resolution conditions are met. These conditions include that a U.K. bank or investment firm is failing or is likely
to fail to satisfy the Financial Services and Markets Act 2000 (the &ldquo;<U>FSMA</U>&rdquo;) threshold conditions for authorization
to carry on certain regulated activities (within the meaning of section 55B FSMA) or, in the case of a U.K. banking group company that
is a European Economic Area (&ldquo;<U>EEA</U>&rdquo;) or third country institution or investment firm, that the relevant EEA or third
country relevant authority is satisfied that the resolution conditions are met in respect of that entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The U.K. Bail-in Power includes any write-down,
conversion, transfer, modification and/or suspension power, which allows for (i) the reduction or cancellation of all, or a portion, of
the principal amount of, or interest on, or any other amounts payable on, the securities; (ii) the conversion of all, or a portion, of
the principal amount of, or interest on, or any other amounts payable on, the securities into shares or other securities or other obligations
of Barclays Bank PLC or another person (and the issue to, or conferral on, the holder or beneficial owner of the securities of such shares,
securities or obligations); (iii) the cancellation of the securities and/or (iv) the amendment or alteration of the maturity of the securities,
or the amendment of the amount of interest or any other amounts due on the securities, or the dates on which interest or any other amounts
become payable, including by suspending payment for a temporary period; which U.K. Bail-in Power may be exercised by means of a variation
of the terms of the securities solely to give effect to the exercise by the relevant U.K. resolution authority of such U.K. Bail-in Power.
Each holder and beneficial owner of the securities further acknowledges and agrees that the rights of the holders or beneficial owners
of the securities are subject to, and will be varied, if necessary, solely to give effect to, the exercise of any U.K. Bail-in Power by
the relevant U.K. resolution authority. For the avoidance of doubt, this consent and acknowledgment is not a waiver of any rights holders
or beneficial owners of the securities may have at law if and to the extent that any U.K. Bail-in Power is exercised by the relevant U.K.
resolution authority in breach of laws applicable in England.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For more information, please see &ldquo;Selected
Risk Considerations&mdash;Risks Relating to the Issuer&mdash;You May Lose Some or All of Your Investment If Any U.K. Bail-in Power Is
Exercised by the Relevant U.K. Resolution Authority&rdquo; in this pricing supplement as well as &ldquo;U.K. Bail-in Power,&rdquo; &ldquo;Risk
Factors&mdash;Risks Relating to the Securities Generally&mdash;Regulatory action in the event a bank or investment firm in the Group is
failing or likely to fail, including the exercise by the relevant U.K. resolution authority of a variety of statutory resolution powers,
could materially adversely affect the value of any securities&rdquo; and &ldquo;Risk Factors&mdash;Risks Relating to the Securities Generally&mdash;Under
the terms of the securities, you have agreed to be bound by the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority&rdquo;
in the accompanying prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Class B Common Stock of Berkshire Hathaway Inc. due December 4, 2028</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Investor
Considerations</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The securities are not appropriate for all
investors. The securities <I>may</I> be an appropriate investment for you if all of the following statements are true:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You do not seek an investment that produces periodic
interest or coupon payments or other sources of current income.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You understand that the absolute value return
feature applies only if the Underlying Stock decreases from the starting price but not by more than 15.00%, that any positive return in
the event that the ending price is less than the starting price is limited to 15.00% and that any decline in the ending price from the
starting price by more than 15.00% will result in a loss, rather than a positive return, on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to accept the risk that,
if the ending price is less than the starting price by more than 15%, you will lose up to 85% of the principal amount of your securities
at maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to accept that any potential return on the securities
if the Underlying Stock appreciates is limited to the maximum upside return.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to accept the risks
associated with an investment linked to the performance of the Underlying Stock, as explained in more detail in the &ldquo;Selected Risk
Considerations&rdquo; section of this pricing supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">You understand and accept that you will not be entitled to receive dividends
or distributions that may be paid to holders of the Underlying Stock, nor will you have any voting rights with respect to the Underlying
Stock.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You do not seek an investment for which there
will be an active secondary market and you are willing and able to hold the securities to maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to assume our credit
risk for all payments on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to consent to the exercise
of any U.K. Bail-in Power by any relevant U.K. resolution authority.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The securities may <I>not</I> be an appropriate
investment for you if <I>any</I> of the following statements are true:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment that produces periodic
interest or coupon payments or other sources of current income.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment that provides for the
full repayment of principal at maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to accept that the
absolute value return feature applies only if the Underlying Stock decreases from the starting price but not by more than 15.00%, that
any positive return in the event that the ending price is less than the starting price is limited to 15.00% or that any decline in the
ending price from the starting price by more than 15.00% will result in a loss, rather than a positive return, on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to accept the risk
that, if the ending price is less than the starting price by more than 15%, you will lose up to 85% of the principal amount of your securities
at maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment with uncapped exposure to any positive performance
of the Underlying Stock.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to accept the risks
associated with an investment linked to the performance of the Underlying Stock, as explained in more detail in the &ldquo;Selected Risk
Considerations&rdquo; section of this pricing supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment that entitles you to dividends or distributions on,
or voting rights related to, the Underlying Stock.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment for which there will be
an active secondary market and/or you are unwilling or unable to hold the securities to maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to assume our credit
risk for all payments on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Class B Common Stock of Berkshire Hathaway Inc. due December 4, 2028</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to consent to the
exercise of any U.K. Bail-in Power by any relevant U.K. resolution authority.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The considerations identified above are not
exhaustive. Whether or not the securities are an appropriate investment for you will depend on your individual circumstances, and you
should reach an investment decision only after you and your investment, legal, tax, accounting and other advisors have carefully considered
the appropriateness of an investment in the securities in light of your particular circumstances. You should also review carefully the
&ldquo;Selected Risk Considerations&rdquo; beginning on page PS-10 of this pricing supplement and the &ldquo;Risk Factors&rdquo; beginning
on page PS-3 of the accompanying product supplement and the &ldquo;Risk Factors&rdquo; beginning on page S-9 of the accompanying prospectus
supplement for risks related to an investment in the securities. For more information about the Underlying Stock, please see the section
titled &ldquo;The Class B Common Stock of Berkshire Hathaway Inc.&rdquo; below.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Class B Common Stock of Berkshire Hathaway Inc. due December 4, 2028</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Determining
the Maturity Payment Amount</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you will receive
a cash payment per security (the maturity payment amount) calculated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;<IMG SRC="image_004.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Class B Common Stock of Berkshire Hathaway Inc. due December 4, 2028</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Selected
Risk Considerations</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An investment in the securities involves significant
risks. Investing in the securities is not equivalent to investing directly in the Underlying Stock. Some of the risks that apply to an
investment in the securities are summarized below, but we urge you to read the more detailed explanation of risks relating to the securities
generally in the &ldquo;Risk Factors&rdquo; sections of the product supplement and prospectus supplement. You should not purchase the
securities unless you understand and can bear the risks of investing in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Securities
Generally</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>If The Ending Price Is Less Than The Threshold
Price, You Will Lose Up To 85% Of The Principal Amount Of Your Securities At Maturity</B> &mdash; If the ending price is less than the
threshold price, the maturity payment amount will be less than the principal amount and you will have full downside exposure to the decrease
in the price of the Underlying Stock in excess of the buffer amount, resulting in a loss of 1% of the principal amount for every 1% decline
in the Underlying Stock in excess of the buffer amount. The threshold price is 85% of the starting price. As a result, you may lose up
to 85% of the principal amount at maturity, even if the price of the Underlying Stock is greater than or equal to the starting price or
the threshold price at certain times during the term of the securities. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Your Potential For A Positive Return From
Depreciation Of The Underlying Stock Is Limited</B> &mdash; The absolute value return feature applies only if the ending price is less
than the starting price but greater than or equal to the threshold price, which is equal to 85.00% of the starting price. Thus, any potential
return on the securities in the event that the ending price is less than the starting price is limited to 15.00%. Any decline in the ending
price from the starting price by more than 15.00% will result in a loss, rather than a positive return, on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Your Return Will Be Limited To The Maximum
Upside Return If the Underlying Stock Appreciates And May Be Lower Than The Return On A Direct Investment In The Underlying Stock</B>
&mdash; The opportunity to participate in the possible increases in the price of the Underlying Stock through an investment in the securities
will be limited because any positive return on the securities if the Underlying Stock appreciates will not exceed the maximum upside return,
regardless of any increase in the price of the Underlying Stock, which may be significant. Therefore, your return on the securities may
be lower than the return on a direct investment in the Underlying Stock. Furthermore, the effect of the upside participation rate will
be progressively reduced for all ending prices exceeding the ending price at which the maximum upside return is reached.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>No Periodic Interest Will Be Paid On The Securities
</B>&mdash; No periodic payments of interest will be made on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Any Payment On The Securities Will Be Determined
Based On The Stock Closing Prices Of The Underlying Stock On The Dates Specified</B> &mdash; Any payment on the securities will be determined
based on the stock closing prices of the Underlying Stock on the dates specified. You will not benefit from any more favorable values
of the Underlying Stock determined at any other time.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Owning The Securities Is Not The Same As Owning
The Underlying Stock</B> &mdash; The return on your securities may not reflect the return you would realize if you actually owned the
Underlying Stock. For instance, as a holder of the securities, you will not have voting rights or rights to receive cash dividends or
other distributions or any other rights that holders of the Underlying Stock would have.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>No Assurance That The Investment View Implicit
In The Securities Will Be Successful</B> &mdash; It is impossible to predict whether and the extent to which the price of the Underlying
Stock will rise or fall. There can be no assurance that the ending price will not be less than the threshold price. The price of the Underlying
Stock will be influenced by complex and interrelated political, economic, financial and other factors that affect the Underlying Stock.
You should be willing to accept the downside risks associated with equities in general and the Underlying Stock in particular, and the
risk of losing up to 85% of the principal amount.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The U.S. Federal Income Tax Consequences Of
An Investment In The Securities Are Uncertain</B> &mdash; There is no direct legal authority regarding the proper U.S. federal income
tax treatment of the securities, and we do not plan to request a ruling from the Internal Revenue Service (the &ldquo;IRS&rdquo;). Consequently,
significant aspects of the tax treatment of the securities are uncertain, and the IRS or a court might not agree with the treatment of
the securities as prepaid forward contracts, as described below under &ldquo;Tax Considerations.&rdquo; If the IRS were successful in
asserting an alternative treatment for the securities, the tax consequences of the ownership and disposition of the securities could be
materially and adversely affected.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In addition, in 2007
the Treasury Department and the IRS released a notice requesting comments on various issues regarding the U.S. federal income tax treatment
of &ldquo;prepaid forward contracts&rdquo; and similar instruments. Any Treasury regulations or other guidance promulgated after consideration
of these issues could materially and adversely affect the tax consequences of an investment in the securities, possibly with retroactive
effect. You should review carefully the sections of the accompanying prospectus supplement entitled &ldquo;Material U.S. Federal Income
Tax Consequences&mdash;Tax Consequences to U.S. Holders&mdash;Notes</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Class B Common Stock of Berkshire Hathaway Inc. due December 4, 2028</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">Treated as Prepaid
Forward Contracts&rdquo; and, if you are a non-U.S. holder, &ldquo;&mdash;Tax Consequences to Non-U.S. Holders,&rdquo; and consult your
tax advisor regarding the U.S. federal tax consequences of an investment in the securities (including possible alternative treatments
and the issues presented by the 2007 notice), as well as tax consequences arising under the laws of any state, local or non-U.S. taxing
jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Issuer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Securities Are Subject To The Credit Risk
Of Barclays Bank PLC</B> &mdash; The securities are unsecured and unsubordinated debt obligations of the issuer, Barclays Bank PLC, and
are not, either directly or indirectly, an obligation of any third party. Any payment to be made on the securities, including any repayment
of principal, is subject to the ability of Barclays Bank PLC to satisfy its obligations as they come due and is not guaranteed by any
third party. As a result, the actual and perceived creditworthiness of Barclays Bank PLC may affect the market value of the securities
and, in the event Barclays Bank PLC were to default on its obligations, you might not receive any amount owed to you under the terms of
the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>You May Lose Some Or All Of Your Investment
If Any U.K. Bail-In Power Is Exercised By The Relevant U.K. Resolution Authority &mdash; </B>Notwithstanding and to the exclusion of any
other term of the securities or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial
owner of the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial
owner of the securities acknowledges, accepts, agrees to be bound by, and consents to the exercise of, any U.K. Bail-in Power by the relevant
U.K. resolution authority as set forth under &ldquo;Consent to U.K. Bail-in Power&rdquo; in this pricing supplement. Accordingly, any
U.K. Bail-in Power may be exercised in such a manner as to result in you and other holders and beneficial owners of the securities losing
all or a part of the value of your investment in the securities or receiving a different security from the securities, which may be worth
significantly less than the securities and which may have significantly fewer protections than those typically afforded to debt securities.
Moreover, the relevant U.K. resolution authority may exercise the U.K. Bail-in Power without providing any advance notice to, or requiring
the consent of, the holders and beneficial owners of the securities. The exercise of any U.K. Bail-in Power by the relevant U.K. resolution
authority with respect to the securities will not be a default or an Event of Default (as each term is defined in the senior debt securities
indenture) and the trustee will not be liable for any action that the trustee takes, or abstains from taking, in either case, in accordance
with the exercise of the U.K. Bail-in Power by the relevant U.K. resolution authority with respect to the securities. See &ldquo;Consent
to U.K. Bail-in Power&rdquo; in this pricing supplement as well as &ldquo;U.K. Bail-in Power,&rdquo; &ldquo;Risk Factors&mdash;Risks Relating
to the Securities Generally&mdash;Regulatory action in the event a bank or investment firm in the Group is failing or likely to fail,
including the exercise by the relevant U.K. resolution authority of a variety of statutory resolution powers, could materially adversely
affect the value of any securities&rdquo; and &ldquo;Risk Factors&mdash;Risks Relating to the Securities Generally&mdash;Under the terms
of the securities, you have agreed to be bound by the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority&rdquo;
in the accompanying prospectus supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Underlying
Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>There Are Risks Associated With Single Equities
</B>&mdash; The price of the Underlying Stock can rise or fall sharply due to factors specific to the Underlying Stock and its issuer,
such as stock price volatility, earnings, financial conditions, corporate, industry and regulatory developments, management changes and
decisions and other events, as well as general market factors, such as general stock market volatility and levels, interest rates and
economic and political conditions. We urge you to review financial and other information filed periodically with the SEC by the issuer
of the Underlying Stock.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>We Cannot Control Actions By The Underlying
Stock Issuer</B> &mdash; Actions by the Underlying Stock Issuer may have an adverse effect on the price of the Underlying Stock, the ending
price and the value of the securities. We are not affiliated with the Underlying Stock Issuer. The Underlying Stock Issuer will not be
involved in the offering of the securities nor will the Underlying Stock Issuer have any obligations with respect to the securities, including
any obligation to take our interests or your interests into consideration for any reason. The Underlying Stock Issuer will not receive
any of the proceeds of the offering of the securities nor will be responsible for, or will have participated in, the determination of
the timing of, prices for, or quantities of, the securities to be issued. The Underlying Stock Issuer will not be involved with the administration,
marketing or trading of the securities nor will have any obligations with respect to any amounts payable on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>We And Our Affiliates Have No Affiliation
With The Underlying Stock Issuer And Have Not Independently Verified Its Public Disclosure Of Information </B>&mdash; We, our affiliates
and WFS and its affiliates are not affiliated in any way with the Underlying Stock Issuer. This pricing supplement relates only to the
securities and does not relate to the Underlying Stock. The material provided in this pricing supplement concerning the Underlying Stock
Issuer is derived from publicly available documents without independent verification. Neither we nor either agent has participated in
the preparation of any of those documents or made any &ldquo;due diligence&rdquo; investigation or any inquiry of the Underlying Stock
Issuer. Furthermore, neither we nor either agent knows whether the Underlying Stock Issuer has disclosed all events occurring before the
date of this pricing supplement, including events that could affect the accuracy or completeness of the publicly available documents referred
to above. Subsequent disclosure of any event of this kind or the disclosure of or failure to disclose material future events concerning
the </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Class B Common Stock of Berkshire Hathaway Inc. due December 4, 2028</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">Underlying Stock
Issuer could affect the value of the securities and any payments on the securities. You, as an investor in the securities, should make
your own investigation into the Underlying Stock Issuer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>You Have Limited Anti-dilution Protection</B>
&mdash; The calculation agent will, in its sole discretion, adjust the adjustment factor of the Underlying Stock for certain events affecting
the Underlying Stock, such as stock splits and stock dividends, and certain other corporate actions involving the Underlying Stock Issuer,
such as mergers. However, the calculation agent is not required to make an adjustment for every corporate event that can affect the Underlying
Stock. For example, the calculation agent is not required to make any adjustments to the adjustment factor of the Underlying Stock if
the Underlying Stock Issuer or anyone else makes a partial tender or partial exchange offer for the Underlying Stock. Consequently, this
could affect the value of the securities and any payments on the securities. See &ldquo;General Terms of the Securities&mdash;Certain
Terms for Securities Linked to an Underlying Stock&mdash;Adjustment Events&rdquo; in the accompanying product supplement for a description
of the general circumstances in which the calculation agent will make adjustments to the adjustment factor of the Underlying Stock. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Securities May Become Linked To The Common
Stock Of A Company Other Than The Original Underlying Stock Issuer </B>&mdash; Following certain corporate events relating to the Underlying
Stock, such as a stock-for-stock merger where the Underlying Stock Issuer is not the surviving entity, the shares of a successor corporation
to the Underlying Stock Issuer will be substituted for the Underlying Stock for all purposes of the securities. Following certain other
corporate events relating to the Underlying Stock in which holders of the Underlying Stock would receive all of their consideration in
cash and the surviving entity has no marketable securities outstanding or there is no surviving entity (including, but not limited to,
a leveraged buyout or other going private transaction involving the Underlying Stock Issuer, or a liquidation of the Underlying Stock
Issuer), the common stock of another company in the same industry group as the Underlying Stock Issuer will be substituted for the Underlying
Stock for all purposes of the securities. In any such event, the equity-linked nature of the securities would be significantly altered.
See &ldquo;General Terms of the Securities&mdash;Certain Terms for Securities Linked to an Underlying Stock&mdash;Adjustment Events&rdquo;
in the accompanying product supplement for a description of the specific events that can lead to these adjustments and the procedures
for selecting a replacement stock. The occurrence of such events and the consequent adjustments may materially and adversely affect the
value of the securities and any payments on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Historical Performance Of The Underlying
Stock Is Not An Indication Of Its Future Performance</B> &mdash; The historical performance of the Underlying Stock should not be taken
as an indication of the future performance of the Underlying Stock. It is impossible to predict whether the stock closing price of the
Underlying Stock will fall or rise during the term of the securities, in particular in the environment in the last several years, which
has been characterized by volatility across a wide range of asset classes. Past fluctuations and trends in the price of the Underlying
Stock are not necessarily indicative of fluctuations or trends that may occur in the future.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to Conflicts
of Interest</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Potentially Inconsistent Research, Opinions
Or Recommendations By Barclays Capital Inc., WFS Or Their Respective Affiliates</B> &mdash; Barclays Capital Inc., WFS or their respective
affiliates may publish research from time to time on financial markets and other matters that may influence the value of the securities
or express opinions or provide recommendations that are inconsistent with purchasing or holding the securities. Any research, opinions
or recommendations expressed by Barclays Capital Inc., WFA or their respective affiliates may not be consistent with each other and may
be modified from time to time without notice. You should make your own independent investigation of the Underlying Stock and the merits
of investing in the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>We, Our Affiliates And Any Other Agent And/Or
Participating Dealer May Engage In Various Activities Or Make Determinations That Could Materially Affect Your Securities In Various Ways
And Create Conflicts Of Interest</B> &mdash; We, our affiliates, WFS and any dealer participating in the distribution of the securities
(a &ldquo;<U>participating dealer</U>&rdquo;) may play a variety of roles in connection with the issuance of the securities, as described
below. In performing these roles, our economic interests and the economic interests of our affiliates, WFS and any participating dealer
are potentially adverse to your interests as an investor in the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In connection with
our normal business activities and in connection with hedging our obligations under the securities, we and our affiliates make markets
in and trade various financial instruments or products for our accounts and for the account of our clients and otherwise provide investment
banking and other financial services with respect to these financial instruments and products. These financial instruments and products
may include securities, derivative instruments or assets that may relate to the Underlying Stock. In any such market making, trading and
hedging activity, investment banking and other financial services, we or our affiliates may take positions or take actions that are inconsistent
with, or adverse to, the investment objectives of the holders of the securities. We and our affiliates have no obligation to take the
needs of any buyer, seller or holder of the securities into account in conducting these activities. Such market making, trading and hedging
activity, investment banking and other financial services may negatively impact the value of the securities. Participating dealers may
also engage in such activities that may negatively impact the value of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Class B Common Stock of Berkshire Hathaway Inc. due December 4, 2028</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In addition, the
role played by Barclays Capital Inc., as the agent for the securities, could present significant conflicts of interest with the role of
Barclays Bank PLC, as issuer of the securities. For example, Barclays Capital Inc. or its representatives may derive compensation or financial
benefit from the distribution of the securities and such compensation or financial benefit may serve as an incentive to sell the securities
instead of other investments. Furthermore, we and our affiliates establish the offering price of the securities for initial sale to the
public, and the offering price is not based upon any independent verification or valuation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">Furthermore, if any
dealer participating in the distribution of the securities or any of its affiliates conducts hedging activities for us in connection with
the securities, that participating dealer or its affiliates will expect to realize a projected profit from such hedging activities, and
this projected profit will be in addition to any selling concession and/or any fee that the participating dealer realizes for the sale
of the securities to you. This additional projected profit may create a further incentive for the participating dealer to sell the securities
to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In addition to the
activities described above, Barclays Bank PLC will also act as the calculation agent for the securities. As calculation agent, we will
determine any prices of the Underlying Stock and make any other determinations necessary to calculate any payments on the securities.
In making these determinations, we may be required to make discretionary judgments, including those described in the accompanying product
supplement and under &ldquo;&mdash;Risks Relating to the Underlying Stock&rdquo; above. In making these discretionary judgments, our economic
interests are potentially adverse to your interests as an investor in the securities, and any of these determinations may adversely affect
any payments on the securities. Absent manifest error, all determinations of the calculation agent will be final and binding, without
any liability on the part of the calculation agent. You will not be entitled to any compensation from Barclays Bank PLC for any loss suffered
as a result of any determinations made by the calculation agent with respect to the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Estimated
Value of the Securities and the Secondary Market</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Securities Will Not Be Listed On Any Securities
Exchange And We Do Not Expect A Trading Market For The Securities To Develop</B> &mdash; The securities will not be listed on any securities
exchange. Barclays Capital Inc. and other affiliates of Barclays Bank PLC intend to make a secondary market for the securities but are
not required to do so, and may discontinue any such secondary market making at any time, without notice. Even if there is a secondary
market, it may not provide enough liquidity to allow you to trade or sell the securities easily. Because other dealers are not likely
to make a secondary market for the securities, the price at which you may be able to trade your securities is likely to depend on the
price, if any, at which Barclays Capital Inc. and other affiliates of Barclays Bank PLC are willing to buy the securities. The securities
are not designed to be short-term trading instruments. Accordingly, you should be willing and able to hold your securities to maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Value Of The Securities Prior To Maturity
Will Be Affected By Numerous Factors, Some Of Which Are Related In Complex Ways</B> &mdash; Structured notes, including the securities,
can be thought of as securities that combine a debt instrument with one or more options or other derivative instruments. As a result,
the factors that influence the values of debt instruments and options or other derivative instruments will also influence the terms and
features of the securities at issuance and their value in the secondary market. Accordingly, in addition to the price of the Underlying
Stock on any day, the value of the securities will be affected by a number of economic and market factors that may either offset or magnify
each other, including:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the expected volatility of the Underlying Stock;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the time to maturity of the securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the market prices of, and dividend rates on,
the Underlying Stock;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">interest and yield rates in the market generally;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">supply and demand for the securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">a variety of economic, financial, political,
regulatory and judicial events; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our creditworthiness, including actual or anticipated
downgrades in our credit ratings.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Estimated Value Of Your Securities Is
Lower Than The Original Offering Price Of Your Securities</B> &mdash; The estimated value of your securities on the pricing date is lower
than the original offering price of your securities. The difference between the original offering price of your securities and the estimated
value of the securities is a result of certain factors, such as any sales commissions, selling concessions, discounts, commissions or
fees to be allowed or paid to Barclays Capital Inc., another affiliate of ours, WFS or its affiliates or other non-affiliated intermediaries,
the estimated profit that we or any of our affiliates expect to earn in connection with structuring the securities, the estimated cost
that we may incur in hedging our obligations under the securities, and estimated development and other costs that we may incur in connection
with the securities.&#9;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Class B Common Stock of Berkshire Hathaway Inc. due December 4, 2028</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Estimated Value Of Your Securities Might
Be Lower If Such Estimated Value Were Based On The Levels At Which Our Debt Securities Trade In The Secondary Market</B> &mdash; The estimated
value of your securities on the pricing date is based on a number of variables, including our internal funding rates. Our internal funding
rates may vary from the levels at which our benchmark debt securities trade in the secondary market. As a result of this difference, the
estimated value referenced above might be lower if such estimated value were based on the levels at which our benchmark debt securities
trade in the secondary market.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Estimated Value Of The Securities Is Based
On Our Internal Pricing Models, Which May Prove To Be Inaccurate And May Be Different From The Pricing Models Of Other Financial Institutions</B>
&mdash; The estimated value of your securities on the pricing date is based on our internal pricing models, which take into account a
number of variables and are based on a number of subjective assumptions, which may or may not materialize. These variables and assumptions
are not evaluated or verified on an independent basis. Further, our pricing models may be different from other financial institutions&rsquo;
pricing models and the methodologies used by us to estimate the value of the securities may not be consistent with those of other financial
institutions that may be purchasers or sellers of securities in the secondary market. As a result, the secondary market price of your
securities may be materially different from the estimated value of the securities determined by reference to our internal pricing models.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Estimated Value Of Your Securities Is
Not A Prediction Of The Prices At Which You May Sell Your Securities In The Secondary Market, If Any, And Such Secondary Market Prices,
If Any, Will Likely Be Lower Than The Original Offering Price Of Your Securities And May Be Lower Than The Estimated Value Of Your Securities</B>
&mdash; The estimated value of the securities will not be a prediction of the prices at which Barclays Capital Inc., other affiliates
of ours or third parties may be willing to purchase the securities from you in secondary market transactions (if they are willing to purchase,
which they are not obligated to do). The price at which you may be able to sell your securities in the secondary market at any time will
be influenced by many factors that cannot be predicted, such as market conditions, and any bid and ask spread for similar sized trades,
and may be substantially less than our estimated value of the securities. Further, as secondary market prices of your securities take
into account the levels at which our debt securities trade in the secondary market, and do not take into account our various costs related
to the securities such as fees, commissions, discounts, and the costs of hedging our obligations under the securities, secondary market
prices of your securities will likely be lower than the original offering price of your securities. As a result, the price at which Barclays
Capital Inc., other affiliates of ours or third parties may be willing to purchase the securities from you in secondary market transactions,
if any, will likely be lower than the price you paid for your securities, and any sale prior to the stated maturity date could result
in a substantial loss to you.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Temporary Price At Which We May Initially
Buy The Securities In The Secondary Market And The Value We May Initially Use For Customer Account Statements, If We Provide Any Customer
Account Statements At All, May Not Be Indicative Of Future Prices Of Your Securities</B> &mdash; Assuming that all relevant factors remain
constant after the pricing date, the price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market
(if Barclays Capital Inc. makes a market in the securities, which it is not obligated to do) and the value that we may initially use for
customer account statements, if we provide any customer account statements at all, may exceed our estimated value of the securities on
the pricing date, as well as the secondary market value of the securities, for a temporary period after the initial issue date of the
securities. The price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market and the value that
we may initially use for customer account statements may not be indicative of future prices of your securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Class B Common Stock of Berkshire Hathaway Inc. due December 4, 2028</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Hypothetical
Examples and Returns</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The payout profile, return table and examples
below illustrate the maturity payment amount for a $1,000 principal amount security on a hypothetical offering of securities under various
scenarios, with the assumptions set forth in the table below. Terms used for purposes of these hypothetical examples do not represent
the actual starting price, threshold price or ending price applicable to the securities. The actual maturity payment amount and resulting
pre-tax total rate of return will depend on the actual terms of the securities. You should not take these examples as an indication or
assurance of the expected performance of the securities. These examples are for purposes of illustration only. The values used in the
examples may have been rounded for ease of analysis. The examples below do not take into account any tax consequences from investing in
the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 36%; border: Black 1pt solid; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Upside Participation Rate:</B></FONT></TD>
    <TD STYLE="width: 64%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">100%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Maximum Upside Return: </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">22.70% of the principal amount or $227.00 per security</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Hypothetical Starting Price: </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Hypothetical Threshold Price: </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">$85.00 (85% of the hypothetical starting price)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Buffer Amount: </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">15%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">The hypothetical
starting price of $100.00 has been chosen for illustrative purposes only and does not represent the actual starting price. The actual
starting price and threshold price are set forth under &ldquo;Terms of the Securities&rdquo; above, and the actual ending price will be
the stock closing price of the Underlying Stock on the calculation day. For historical closing prices of the Underlying Stock, see the
historical information set forth under the section </FONT>titled &ldquo;The Class B Common Stock of Berkshire Hathaway Inc.&rdquo; below.
We cannot predict the stock closing price of the Underlying Stock on any day during the term of the securities, including on the calculation
day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical Payout Profile </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 347px; width: 552px"></FONT></P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Class B Common Stock of Berkshire Hathaway Inc. due December 4, 2028</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical Returns</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Georgia, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 24%; border: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical<BR>
ending price</B></FONT></TD>
    <TD STYLE="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical<BR>
stock return</B></FONT></TD>
    <TD STYLE="width: 19%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Absolute value return</B></FONT></TD>
    <TD STYLE="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical maturity payment amount per security</B></FONT></TD>
    <TD STYLE="width: 17%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical pre-tax total rate of return</B></FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$175.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,227.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.70%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$150.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,227.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.70%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$140.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,227.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.70%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$130.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,227.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.70%</FONT></TD></TR>
  <TR STYLE="background-color: #BFBFBF">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$122.70</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.70%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,227.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.70%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$120.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,200.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$110.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,100.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$105.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,050.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.00%</FONT></TD></TR>
  <TR STYLE="background-color: #CCCCCC">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$100.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$95.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-5.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,050.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$90.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-10.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,100.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.00%</FONT></TD></TR>
  <TR STYLE="background-color: #BFBFBF">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$85.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-15.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,150.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$84.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-16.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$990.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$75.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-25.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$900.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-10.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$50.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-50.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$650.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-35.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$25.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-75.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$400.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-60.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-100.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$150.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-85.00%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Hypothetical Examples</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 1. Maturity payment amount is greater
than the principal amount and reflects a return that is less than the maximum upside return:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">Hypothetical starting price: $100.00<BR>
Hypothetical ending price: $110.00<BR>
Hypothetical threshold price: $85.00<BR>
Hypothetical stock return: 10.00%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending price is greater
than the hypothetical starting price, the maturity payment amount per security would be equal to the principal amount of $1,000 <I>plus</I>
a positive return equal to the <I>lesser</I> of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(i) $1,000 &times; stock return &times; upside
participation rate</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $1,000 &times; 10.00% &times; 100%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $100.00; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(ii) the maximum upside return of $227.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you would receive
$1,100.00 per security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 2. Maturity payment amount is greater
than the principal amount and reflects a return equal to the maximum upside return:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">Hypothetical starting price: $100.00<BR>
Hypothetical ending price: $140.00<BR>
Hypothetical threshold price: $85.00<BR>
Hypothetical stock return: 40.00%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending price is greater
than the hypothetical starting price, the maturity payment amount per security would be equal to the principal amount of $1,000 <I>plus</I>
a positive return equal to the <I>lesser</I> of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Class B Common Stock of Berkshire Hathaway Inc. due December 4, 2028</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(i) $1,000 &times; stock return &times; upside
participation rate</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $1,000 &times; 40.00% &times; 100%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $400.00; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(ii) the maximum upside return of $227.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you would receive
$1,227.00 per security, which is the maximum maturity payment amount if the Underlying Stock appreciates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 3. Maturity payment amount is greater
than the principal amount and reflects the absolute value return:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">Hypothetical starting price: $100.00<BR>
Hypothetical ending price: $90.00<BR>
Hypothetical threshold price: $85.00<BR>
Hypothetical stock return: -10.00%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending price is less
than the hypothetical starting price, but not by more than 15%, the maturity payment amount per security would be equal to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,000 + ($1,000 &times; absolute value return)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Because the stock return is -10.00%, the absolute value return is +10.00%
and the maturity payment amount is calculated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $1,000 + ($1,000 &times; 10.00%)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $1,100.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you would receive
$1,100.00 per security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 4. Maturity payment amount is less
than the principal amount:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">Hypothetical starting price: $100.00<BR>
Hypothetical ending price: $50.00<BR>
Hypothetical threshold price: $85.00<BR>
Hypothetical stock return: -50.00%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending price is less
than the hypothetical starting price by more than 15%, you would lose a portion of the principal amount of your securities and receive
the maturity payment amount equal to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,000 + [$1,000 &times; (stock return + buffer
amount)]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $1,000 + [$1,000 &times; (-50.00% + 15%)]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $650.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you would receive
$650.00 per security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Class B Common Stock of Berkshire Hathaway Inc. due December 4, 2028</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">The
Class B Common Stock of Berkshire Hathaway Inc.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to publicly available information, Berkshire
Hathaway Inc. is a holding company owning subsidiaries engaged in insurance businesses, a freight rail transportation business, a group
of utility and energy generation and distribution businesses and others. Information filed by Berkshire Hathaway Inc. with the SEC under
the Exchange Act can be located by reference to its SEC file number: 001-14905. The Class B common stock of Berkshire Hathaway Inc. is
listed on the New York Stock Exchange under the ticker symbol &ldquo;BRK.B.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We urge you to read the following section in the
accompanying prospectus supplement: &ldquo;Reference Assets &mdash; Equity Securities &mdash; Reference Asset Issuer and Reference Asset
Information.&rdquo; Companies with securities registered under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;),
are required to file financial and other information specified by the SEC periodically. Such information can be reviewed electronically
through a website maintained by the SEC at http://www.sec.gov. Information filed with the SEC by the Underlying Stock Issuer can be located
by reference to its SEC file number provided above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The brief description of the Underlying Stock
Issuer included above has been obtained from publicly available sources. Information from outside sources is not incorporated by reference
in, and should not be considered part of, this pricing supplement or any accompanying prospectus or prospectus supplement. We have not
independently verified the accuracy or completeness of the information contained in outside sources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Historical Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We obtained the closing prices of the Underlying
Stock displayed in the graph below from Bloomberg Professional<SUP>&reg;</SUP> service without independent verification. The historical
performance of the Underlying Stock should not be taken as an indication of the future performance of the Underlying Stock. Future performance
of the Underlying Stock may differ significantly from historical performance, and no assurance can be given as to the closing prices of
the Underlying Stock during the term of the securities, including on the calculation day. We cannot give you assurance that the performance
of the Underlying Stock will not result in a loss on your initial investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following graph sets forth daily closing prices
of the Underlying Stock for the period from January 1, 2021 to May 29, 2026. The closing price on May 29, 2026 was $474.48. <I>The closing
prices below may reflect adjustments in response to certain corporate actions, such as stock splits, public offerings, mergers and acquisitions,
spin-offs, extraordinary dividends, delistings and bankruptcy.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Georgia, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><IMG SRC="image_003.jpg" ALT="" STYLE="height: 322px; width: 614px"></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">* The dotted line indicates the threshold price of 85% of the starting price.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">PAST PERFORMANCE IS NOT
INDICATIVE OF FUTURE RESULTS.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Class B Common Stock of Berkshire Hathaway Inc. due December 4, 2028</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Tax
Considerations</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should review carefully the sections in the
accompanying prospectus supplement entitled &ldquo;Material U.S. Federal Income Tax Consequences&mdash;Tax Consequences to U.S. Holders&mdash;Notes
Treated as Prepaid Forward Contracts&rdquo; and, if you are a non-U.S. holder, &ldquo;&mdash;Tax Consequences to Non-U.S. Holders.&rdquo;
The following discussion, when read in combination with those sections, constitutes the full opinion of our special tax counsel, Davis
Polk &amp; Wardwell LLP, regarding the material U.S. federal income tax consequences of owning and disposing of the securities. As discussed
in the section entitled &ldquo;Material U.S. Federal Income Tax Consequences&rdquo; in the accompanying prospectus supplement, we have
not attempted to ascertain whether any issuer of any shares (or other equity interests) to which a security relates is a U.S. real property
holding corporation (&ldquo;USRPHC&rdquo;) or a passive foreign investment company (&ldquo;PFIC&rdquo;). If any such issuer were so treated,
certain adverse U.S. federal income tax consequences might apply, to a U.S. holder in the case of a PFIC, or to a non-U.S. holder in the
case of a USRPHC. You should consult your tax advisor regarding these issues, including the effect any circumstances specific to you may
have on the U.S. federal income tax consequences of your ownership of a security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on current market conditions, in the opinion
of our special tax counsel, it is reasonable to treat the securities for U.S. federal income tax purposes as prepaid forward contracts
with respect to the Underlying Stock. Assuming this treatment is respected, if you are a U.S. holder, upon a sale or exchange of the securities
(including redemption at maturity), you should recognize capital gain or loss equal to the difference between the amount realized on the
sale or exchange and your tax basis in the securities, which should equal the amount you paid to acquire the securities. This gain or
loss on your securities should be treated as long-term capital gain or loss if you hold your securities for more than a year, whether
or not you are an initial purchaser of the securities at the original issue price. The deductibility of capital losses is subject to limitations.
However, the IRS or a court may not respect this treatment, in which case the timing and character of any income or loss on the securities
could be materially and adversely affected. In addition, in 2007 the U.S. Treasury Department and the IRS released a notice requesting
comments on the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo; and similar instruments. The notice focuses
in particular on whether to require investors in these instruments to accrue income over the term of their investment. It also asks for
comments on a number of related topics, including the character of income or loss with respect to these instruments; the relevance of
factors such as the nature of the underlying property to which the instruments are linked; the degree, if any, to which income (including
any mandated accruals) realized by non-U.S. investors should be subject to withholding tax; and whether these instruments are or should
be subject to the &ldquo;constructive ownership&rdquo; regime, which very generally can operate to recharacterize certain long-term capital
gain as ordinary income and impose a notional interest charge. While the notice requests comments on appropriate transition rules and
effective dates, any Treasury regulations or other guidance promulgated after consideration of these issues could materially and adversely
affect the tax consequences of an investment in the securities, possibly with retroactive effect. You should consult your tax advisor
regarding the U.S. federal income tax consequences of an investment in the securities, including possible alternative treatments and the
issues presented by this notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Treasury regulations under Section 871(m) generally
impose a withholding tax on certain &ldquo;dividend equivalents&rdquo; under certain &ldquo;equity linked instruments.&rdquo; A recent
IRS notice excludes from the scope of Section 871(m) instruments issued prior to January 1, 2027 that do not have a &ldquo;delta of one&rdquo;
with respect to underlying securities that could pay U.S.-source dividends for U.S. federal income tax purposes (each an &ldquo;Underlying
Security&rdquo;). Based on our representation that the securities do not have a &ldquo;delta of one&rdquo; within the meaning of the regulations,
our special tax counsel believes that these regulations should not apply to the securities with regard to non-U.S. holders, and we have
determined to treat the securities as not being subject to Section 871(m). Our determination is not binding on the IRS, and the IRS may
disagree with this determination. Section 871(m) is complex and its application may depend on your particular circumstances, including
whether you enter into other transactions with respect to an Underlying Security. You should consult your tax advisor regarding the potential
application of Section 871(m) to the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-U.S. holders should also discuss with their
tax advisors the estate tax consequences of investing in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Class B Common Stock of Berkshire Hathaway Inc. due December 4, 2028</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Validity
of the Securities</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of Davis Polk &amp; Wardwell LLP,
as special United States products counsel to Barclays Bank PLC, when the securities offered by this pricing supplement have been executed
and issued by Barclays Bank PLC and authenticated by the trustee pursuant to the indenture, and delivered against payment as contemplated
herein, such securities will be valid and binding obligations of Barclays Bank PLC, enforceable in accordance with their terms, subject
to applicable bankruptcy, insolvency and similar laws affecting creditors&rsquo; rights generally, concepts of reasonableness and equitable
principles of general applicability (including, without limitation, concepts of good faith, fair dealing and the lack of bad faith) and
possible judicial or regulatory actions or application giving effect to governmental actions or foreign laws affecting creditors&rsquo;
rights, <I>provided </I>that such counsel expresses no opinion as to (i) the effect of fraudulent conveyance, fraudulent transfer or similar
provision of applicable law on the conclusions expressed above or (ii) the validity, legally binding effect or enforceability of any provision
that permits holders to collect any portion of the stated principal amount upon acceleration of the securities to the extent determined
to constitute unearned interest. This opinion is given as of the date hereof and is limited to the laws of the State of New York. Insofar
as this opinion involves matters governed by English law, Davis Polk &amp; Wardwell LLP has relied, with Barclays Bank PLC&rsquo;s permission,
on the opinion of Davis Polk &amp; Wardwell London LLP, dated as of May 15, 2025, filed as an exhibit to the Registration Statement on
Form F-3ASR by Barclays Bank PLC on May 15, 2025, and this opinion is subject to the same assumptions, qualifications and limitations
as set forth in such opinion of Davis Polk &amp; Wardwell London LLP. In addition, this opinion is subject to customary assumptions about
the trustee&rsquo;s authorization, execution and delivery of the indenture and its authentication of the securities and the validity,
binding nature and enforceability of the indenture with respect to the trustee, all as stated in the opinion of Davis Polk &amp; Wardwell
LLP, dated May 15, 2025, which has been filed as an exhibit to the Registration Statement referred to above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</FONT></P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp247733_exfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024-2025 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.2b -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: 4c50ac9aec6e5e24c3293f98d0e477d1 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
  <title>Filing Fee Exhibit</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="fee_001">424B2</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="fee_002">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="fee_003">0000312070</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="fee_004">333-287303</ix:nonNumeric>
      <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="c_report" xs:nil="true" id="fee_005"></ix:nonNumeric>
      <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="c_report" id="fee_006">N/A</ix:nonNumeric>
      <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="c_report" id="fee_007">N/A</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000312070</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2026-06-02</xbrli:startDate>
          <xbrli:endDate>2026-06-02</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000312070</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2026-06-02</xbrli:startDate>
          <xbrli:endDate>2026-06-02</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: right">Ex-Filing Fees</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">CALCULATION OF FILING FEE TABLES</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="fee_008">F-3</ix:nonNumeric></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="fee_009">BARCLAYS BANK PLC</ix:nonNumeric></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="fee_010">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="fee_011">Debt</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="fee_012">Global Medium-Term Notes, Series A</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457rFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="fee_013">457(r)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_014">986</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_015">1,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_016">986,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_017">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-223">136.17</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-224">986,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-225">136.17</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-226">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-227">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-228">136.17</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="ixv-229">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), was originally deferred in accordance with Rule 456(b) under the Securities Act.</ix:nonNumeric></td></tr>
  </table>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Narrative Disclosure</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">
The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="c_report" id="ixv-230">986,000</ix:nonFraction>.
<ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="c_report" format="ixt:booleantrue" id="ixv-231">The prospectus is a final prospectus for the related offering.</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">&#160;</p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  J +,# 2(  A$! Q$!_\0
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M^ Q6#X[F5=0L$8_<RY'MD?X5Y49*5:Z/H:D'3PJBREJYU)#;MKD!:R5A\D#
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$@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &H KT# 2(  A$! Q$!_\0
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M44*!^ J2M?9>9E[;R/0O^$[\'_\ 0UZ'_P"#&'_XJC_A._!__0UZ'_X,8?\
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MH_X2+Q1_T -'_P#!Q+_\C5/11[606(/^$B\4?] #1_\ P<2__(U'_"1>*/\
MH :/_P"#B7_Y&J>BCVL@L0?\)%XH_P"@!H__ (.)?_D:C_A(O%'_ $ -'_\
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ME_\ D:C_ (2+Q1_T -'_ /!Q+_\ (U3T4>UD%B#_ (2+Q1_T -'_ /!Q+_\
M(U'_  D7BC_H :/_ .#B7_Y&J>BCVL@L0?\ "1>*/^@!H_\ X.)?_D:C_A(O
M%'_0 T?_ ,'$O_R-4]%'M9!8@_X2+Q1_T -'_P#!Q+_\C4?\)%XH_P"@!H__
M (.)?_D:IZ*/:R"Q!_PD7BC_ * &C_\ @XE_^1J/^$B\4?\ 0 T?_P '$O\
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M'L]3^R_:EG)M9!+"8[B2,A@,9.UAGC/7/4^M,.A:<=4;4?)<7#,'8"9Q&S
M!FCSL+  88C/ YX%)-6&<^?$^KQZ'?>(G@LFTQ(YC!;JL@G5UDV)N/(8'!)P
M 5X'S=:JWFJ:CJ?AF]%]:QLMO?6R[Y["XMDN8R\9!5'=74JYZY(.WI@\=,OA
MK2$DNF^QAEN@XEB>1FC^?[^$)VKN[[0,]Z8_A;2I-.DL9$NGAD=7=FO9C(Q4
MY4&3?OP#R!G IW0C G\4ZS8Z7=W-P;&6?3FN%O((K9UR5($6T^8Q7<'1N0V0
M3CIS<M=?U>7P[K5S)"J7-@K/!/+I\UO'.HC#Y\J0AQSN7[W;/?%;[:1I\@O
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MM1;QP>2UN8E?&1(7!(#9X  "@XI60SH=/\6Z%J&DVNHIJ=K#!<L$033HI$A
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MN/O?&TNGP31W5C:07T%T+:837I2W3,?F*WG>7P&& -RCG(.."8%UVZ_M34+
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M#_\ !M-_\C4?8_&'_0*T/_P;3?\ R-7:44>SCV"YQ?V/QA_T"M#_ /!M-_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<;JGQ#L+::
M2WTJTFU6:,E7>%E2%&'!4R-U.?[H;'?%"5Q-VW.RHKSO_A86N=O#>GX]]6<'
M_P!)Z/\ A86N_P#0N:;_ .#9_P#Y'JN278GGCW/1**\[_P"%A:[_ -"YIO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&:]O9TM[:%=\DKG 45RLOB'6]6_Y!5M'IMF?NW-ZA:9QZK#QM^K'/JM)R2W
M[*J]S?V=DN;J[@@'K+(%_F:XI]$-WSJ>JZG?L>H>Z:*/_OW%M4_B#3K?PUH5
MJ=T&C6"-W86Z;B?<XR:R=5#L;[^,_"T7^L\2Z.G^]?1#_P!FJ/\ X3OP?_T-
M>A_^#&'_ .*JHEO#%_JXD3_=4"I*7MO(+$__  G?@_\ Z&O0_P#P8P__ !5'
M_"=^#_\ H:]#_P#!C#_\54%%'MO(+$__  G?@_\ Z&O0_P#P8P__ !5'_"=^
M#_\ H:]#_P#!C#_\54%%'MO(+$__  G?@_\ Z&O0_P#P8P__ !5'_"=^#_\
MH:]#_P#!C#_\54%%'MO(+$__  G?@_\ Z&O0_P#P8P__ !5'_"=^#_\ H:]#
M_P#!C#_\54%%'MO(+$__  G?@_\ Z&O0_P#P8P__ !5'_"=^#_\ H:]#_P#!
MC#_\54%%'MO(+$__  G?@_\ Z&O0_P#P8P__ !5'_"=^#_\ H:]#_P#!C#_\
M54%%'MO(+$__  G?@_\ Z&O0_P#P8P__ !5'_"=^#_\ H:]#_P#!C#_\54%%
M'MO(+$__  G?@_\ Z&O0_P#P8P__ !5'_"=^#_\ H:]#_P#!C#_\54%%'MO(
M+$__  G?@_\ Z&O0_P#P8P__ !5'_"=^#_\ H:]#_P#!C#_\54%%'MO(+$__
M  G?@_\ Z&O0_P#P8P__ !5'_"=^#_\ H:]#_P#!C#_\54%%'MO(+$__  G?
M@_\ Z&O0_P#P8P__ !5'_"=^#_\ H:]#_P#!C#_\54%%'MO(+$__  G?@_\
MZ&O0_P#P8P__ !5'_"=^#_\ H:]#_P#!C#_\54%%'MO(+$__  G?@_\ Z&O0
M_P#P8P__ !5'_"=^#_\ H:]#_P#!C#_\54%%'MO(+$__  G?@_\ Z&O0_P#P
M8P__ !5'_"=^#_\ H:]#_P#!C#_\54%%'MO(+$__  G?@_\ Z&O0_P#P8P__
M !5'_"=^#_\ H:]#_P#!C#_\54%%'MO(+$__  G?@_\ Z&O0_P#P8P__ !5'
M_"=^#_\ H:]#_P#!C#_\54%%'MO(+$__  G?@_\ Z&O0_P#P8P__ !5'_"=^
M#_\ H:]#_P#!C#_\54%%'MO(+$__  G?@_\ Z&O0_P#P8P__ !5'_"=^#_\
MH:]#_P#!C#_\54%%'MO(+$__  G?@_\ Z&O0_P#P8P__ !5'_"=^#_\ H:]#
M_P#!C#_\54%%'MO(+$__  G?@_\ Z&O0_P#P8P__ !5'_"=^#_\ H:]#_P#!
MC#_\54%%'MO(+$__  G?@_\ Z&O0_P#P8P__ !5'_"=^#_\ H:]#_P#!C#_\
M54%%'MO(+$__  G?@_\ Z&O0_P#P8P__ !5'_"=^#_\ H:]#_P#!C#_\54%%
M'MO(+$__  G?@_\ Z&O0_P#P8P__ !5'_"=^#_\ H:]#_P#!C#_\54%%'MO(
M+$__  G?@_\ Z&O0_P#P8P__ !5'_"=^#_\ H:]#_P#!C#_\54%%'MO(+$__
M  G?@_\ Z&O0_P#P8P__ !5'_"=^#_\ H:]#_P#!C#_\54%%'MO(+$__  G?
M@_\ Z&O0_P#P8P__ !5'_"=^#_\ H:]#_P#!C#_\54%%'MO(+%A?'/A%CA?%
M.B$^@U"+_P"*JW;^)-"NVVVVM:=,WI%=(Q_0UEE588(!'H:JSZ9I]RN)[&VE
M'I)$K?S%'M?(+'8JP905((/0@TM>?CPMHT3%K6R%BY_BL)'M3^<96K$2:_IN
M#8:T;N-?^7?4D#@CT$B@./JV^J55!8[BBL#1_%$-_>C3;VV?3]4VEUMY&W)*
MHZF)^ X'&1PP[@5OUJG<1Y=XP_Y*%<_]@JT_]&W-9U:/C#_DH5S_ -@JT_\
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M9ZBKM<#!X?O=.;PU!:V&K(MC#' 9X[FVD B\Q28YU?;G"JIW1 D'.T\#/?4
M%%%% '(>*?\ 2?%&@V,G-NL5S>[.S21F%4)'?'FL1[@&K%0>(?\ D>-$_P"P
M;??^C+2IZY:OQ#1R\GB;4X[W5;$Z3:B\M/*-K";Y@;M)&(5@?+^7D$=\$')
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ME37<%M90PQW*9VS*J !Q@$8(&>IZUE439M2:5[G<T5S7_"2ZE_T+]S_X]_\
M$T?\)+J7_0OW/_CW_P 367(S7G1TM%<U_P )+J7_ $+]S_X]_P#$T?\ "2ZE
M_P!"_<_^/?\ Q-'(PYT=+3$ECD9U2169#A@K9*GW]*YW_A)=2_Z%^Y_\>_\
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M;L'!!SGI70:^=6DUW3;+3=7>P6YAF+XMXY1E-A!PPS_%@\]/0\@Y0.EHKA=
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 8GC+_D1_$'_ &#;G_T6U>A5Y[XR_P"1'\0?]@VY_P#1;5Z%712V8F>7
M>,./B%<>^E6N/PEN?\16=71?$6P:UN;+Q BDP1(;6\(&=B,04<^RMD'_ '\]
MJYWZ5W4W[IR5%[P4445H9A1110 4444 %%%% !1110 4444 %%%%  2%!).
M*]#\# K\/O#:D8(TJU!'_;):\SNHI[YXM)LL_;;\F&(@9\M3]Z0^RCG\AU(K
MV6TM8K&S@M(%VPP1K'&OHJC 'Y"L*KUL=%):7)J***R-@HHHH **** .0\1<
M>-]#)X']G7P'U\RUX_0_E5BKOB+0WU>WAEM)UM]1M',EK*P+)DC!5P.JL.#W
MZ$<BN;_ML6,BVVNV[:5<D[0TIS!(?]B; 4Y]#AO:N>I%WN-&O12*P90RD%2,
M@@\&EK$84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M./8P?#OA2P\.B66)I+F]F $UW.078#^$8 "K_L@8^IYK>HHJ"PHHHH ****
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M_@GE_P#DFNNHHY(]@.1_X1WQ1_T']'_\$\O_ ,DT?\([XH_Z#^C_ /@GE_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME_\ D:I**.9A8C_X23Q/_P!"_I'_ (.)?_D:JUMJWB"TGN)8O#NCJ]P^]_\
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MD4B3;%+'T7@=0O++G()Y[ZL2#PKIEMK4FI1Q.'?+"/S7V)(2Q9U7=M5CN/(
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M99 %.5"N[%EP>1@C!Y'/-7-/TNTTN.1;5) 96WR22RO*[G&!N=R6/  &3P*
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M &^]D!L,3W+ D]ZBO_"^DZE=M=W,$WG-Y99HKF6($QG<C$(P&Y3T;K[TM!F
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M444 %%%% !1110 4444 %%%% '/^._\ DGOB7_L%77_HIJIU<\=_\D]\2_\
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M9%ZQCY.7[[1\V.<8J>3Q1I$=C;7@N))(;F,RQ>3;R2.4&-S%%4LH&0"2!@D
MX)HL!L45D77B?2+-YDFN)/W,23.4MY'7RW.%<%5(*\'D9 [XIK^*='CU-M.>
MXE6Y698&4VTH57;&P%MNT;L_*2<-VS2L!LT5AZ1XHL]4L+Z\=)K.&SEE21[F
M*2-0J,PW9=5[+DCJO0U!J?BZSM=$N;ZU2Y>6*1(?*DLIE='? 4M&5#;><YP
M<8!S3L!T=%946K1VJZ;;7\S/>7V1$8K*6-7(&[!4[O+.WLQSP?0XA7Q9H["(
M^?.HDP?FM)E\L%BH,F5_=@D$ O@'!QTI6 VZ*R6\2:6EVUJTTRRI<K:,#;2X
M65@"H)VX ((PW0YZT:=XDTK5;^6QL[AWN8@Q>-X)$*[6"L/F4<@D<=>0>A%%
M@-:BBB@ HHHH *7P7_Q]^)_^PJO_ *1VU)2^"_\ C[\3_P#857_TCMJN&XF=
M71116A(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+23"0^1B*XDB#1YR%;:PW<DGG///6MNBG<#(_P"$9TO;?*4NB+] ESNO9CO
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\(WXG_Z&#2/_  3R_P#R31_PC?B?_H8-(_\ !/+_ /)-%%'*@N'_  C?B?\
MZ&#2/_!/+_\ )-'_  C?B?\ Z&#2/_!/+_\ )-%%'*@N'_"-^)_^A@TC_P $
M\O\ \DT?\(WXG_Z&#2/_  3R_P#R3111RH+A_P (WXG_ .A@TC_P3R__ "31
M_P (WXG_ .A@TC_P3R__ "3111RH+A_PC?B?_H8-(_\ !/+_ /)-'_"-^)_^
MA@TC_P $\O\ \DT44<J"X?\ "-^)_P#H8-(_\$\O_P DT?\ "-^)_P#H8-(_
M\$\O_P DT44<J"X?\(WXG_Z&#2/_  3R_P#R31_PC?B?_H8-(_\ !/+_ /)-
M%%'*@N'_  C?B?\ Z&#2/_!/+_\ )-'_  C?B?\ Z&#2/_!/+_\ )-%%'*@N
M'_"-^)_^A@TC_P $\O\ \DT?\(WXG_Z&#2/_  3R_P#R3111RH+A_P (WXG_
M .A@TC_P3R__ "31_P (WXG_ .A@TC_P3R__ "3111RH+A_PC?B?_H8-(_\
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<% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %; B@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-S&V[8?,MG4*Q3S%!)'4J,BJ+> X&M)+?^T;C;*\LTA90299(FCD?VSNW8Z
MCWJ[-X3@GG>1[J7#W,<Y4 ?P0^5C\1S]: )9O%NE0B >9-(\Z1/$D<+,SB4,
M4P .X1OICFIM(\2:;KDA2RDE)\H3+YD3)O0DC<,CD9!!]ZS+'P9]EN[2YFU.
M6=K40+&/*51MB615!QW(D.3[=JNZ-X:BT:>"5+F24PV8M &4#(#E]WUYQ0!8
MOM7TS3+J=KEMDT5K]HD81DGR@V.H]STJJWC'1HWN1+/+&EN95:62%E1FC^^J
MDCDCVINO^&/[;G>5+^2U\ZU:TF"QAMT98-QGH<CKSUJC9^%+R22=[^] 1+J[
MEM(5B5E3S2P#-G[WRL?E([GKQ0!IS>)[&W2*6X,MM&R2LRW$+H_R;<X&.?O#
M'KD8S56W\96LDMVDUK=1O%<&&.$0L99 (U=FV8R -W\O7%5%\ 6QM_*>\=1F
M5E6&,)'&S[,;$Y"@&,''0DFEN? _VV=KR[U!9[XRM)YDEJC1@,BH5V$_["D'
M.<^HXH ZJVN8;RUBN;>19(94#QNO1E(R#4M5["SCT[3[>SB),<$:QJ2 ,@#'
M0 #\A5B@ HHHH **** "BBB@ HHJK<7\4$\,(26625MH$:;MOJ2>@ H M$@#
M).!6<]_+=>?#IJ!I8F"&692(P>^#_$1Z#\Z;_9TM_&!JQCD DWK#$6" =@W]
M[UYXK3H IP:=%'=M>2,\ERZA2S,< =PJ] ,\U<HHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "N2F\"P7%N;.6[/V*,W#VZ)'M>-YB2Q+9PV"3C@>^
M<5UM% &%!X>8IJ,M]/!=7E]LW2&V'EIL7"80D]#EN3U-16/A.&PUX:C%<'RE
M!*Q%/FW%%0DOGD87.,=23FNBHH \V^-.E6$_@TZG+9PO?6]Q;I#<,OSQJTR9
M /O7I-<#\9/^2<W/_7W:_P#HY*[Z@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "H+Z1XM/N9(SB1(F9>,\@'%3T4 >:76M>(;*VT__ $Z5GFTZ
M.Z268*OG7#'YH]HC.X#Y?D7#?,>?1D.LWNBVFJK]NG#%-1=!*H<BY$H,:K\N
M2=IR%[@YZ5Z=10!PK7FLS3LW]I748DUA+((D282'RPQ(RO7.?F-='X8NKJ\\
M/V\UX[//ND1G90I8+(R@D#O@"M>B@ HHHH **** "BBB@#G/"^J7DUUJVC:I
M+YFH:=<G$FT+YMO)EHGP..F5/NAKHZY#Q3_Q(O$.D^*4X@##3]1/;R9&&QS_
M +DF/P=JZ^@ HHHH **** "BBB@ HHHH **** "BBFNZ1(7D=41>2S' % #J
MAN+F*UB:25CA5+;5&6('H!R:J275S=M<6]E&T+1X47,T?R$YYVC.3@=^E30:
M=!#<?:F42790(T[#D@>G8?04 1+]LOGBDR;:T9#OB=<2DG(P3GY>QXYJS9V=
MO86X@MHQ'&#G&<DGN23R3[U/10 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5$]U;QRF)YXED"&38S@'8."V/3WJ6O-M9\/Z]=ZSJT[V<
M,LMWIDT*S13,04$B%(@"H )4'C/)+'- '=+K>E-8F]74K0VH;89A,NP-Z9SC
M/-7%FB>1HTD1G0 LH.2,],_6N)DTB36+C6-16*[M(6>&2W5[;#NR0LC_ +ML
M'E7VC..5!Z"IO#UOK>FZ\+&6.0V7E@NQC!3 C3:1)U+!LIM]%!QWH J?&3_D
MG-S_ -?=K_Z.2N^KS#XUKK)\+(UL]B-($\'VI9%;SR_G+MV$?+C/7->GT %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!4U33K?5]*N]-NTWV]U$T4@]F&/SK&\$:C<7>A&QU!]VIZ7*
MUC=D]79,;7^CH5;\:Z2N0U'_ (I[Q]9:H/ELM;46%UZ+<+DPN?J-R?\ ?- '
M7T444 %%%% !1110 4444 %%07%Y#;?*S;I2I98DY=P.N!WJM&E[>F":5FM(
M=I+VV 68\XW-V&.P_.@!\^HJDD<=O"]T[/L;RB"L>,9W'H,9Z=:C&FFY#?VF
MZ70\S?''LPB8Z<=_QJW;6L%G L%M$D4:]%48%34 '2BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#F?$,^M#4H8M":8W2Q;W201_90
M"W!D)^<'@CY??TK2T&^O;^P+W\,"2JVT2VS[X9UV@B2,]=ISC![@]>M<SKEA
MIR>))/M45A#+- )#<S::91(-S#82&ZC]<^U=E8+&FG6RQ&,QB)0ICCV+C'&%
M[#V[4 6**** "BBB@#@?C)_R3FY_Z^[7_P!')7?5P/QD_P"2<W/_ %]VO_HY
M*[Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "LGQ+HJ^(/#UYII?RY)4S#*.L4JG<CCZ, ?PK6IDR
MR/!(L4GER,I"OMW;3C@X[T 8_A77#KGAVUO+A1%><P741/\ JYT)5U_[Z!Q[
M8K;KY\T7PWXLT?X[Z8?$5P]U!=3SW$=S$-L$K>2V2%'"M@#(Z\=^M?0= !11
M10 445GRZD9,+I\0O&\SRW*R +'CKN/]!0!<GGBMH6EGD2.->2SG %4GGN[U
MYX+:-[:, ;+MP&W'C[J]^.YI\>G!I)'O)3=EI Z+(HVQXSC:/7GK5Z@"@8[#
M2HFO+J6)&5%22[G8!B.@RU*VLZ6HMBVHV@%U_J"9E_>]OEYYY(Z>M4?%,I@T
MZ"6/3&O[E+A&@41LZQ2<XD8*"<+R>!GI]:Y2328!%;:0EG?&&XB#7VIMI\N^
M0><SF)%"_)ERQYQM!&,G! !WE]JFGZ8%:_O;>V#9*F:0(#CKUI$U73I+F.V2
M_MFGE021QB52S*1D,!GD8YK,\2Q3:I80:=!%,8;J\2"[(0C$(RS_ / 6"[<]
M#NK!O-(N9K^YTTV<^9]8CNEN$C(1;<1JI^?H" K)CKR.,&@#M+?4;*ZB26WN
MX)8Y'*(T<@8,PSD CJ>#^56:\YFTK7-#<2Z;Y\Q61HD86P.YEB54)7G:K;%4
MMZ G(W5Z*,X&>O>@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW+*S&*(HH"C '+,Q[GDGKQBMFN!F\1ZS9^(I;%I3(MO<I"(Y!'NGB,>XR;5
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MZEXAM[:8V5G&][?D$""'G;_O'HM9MO9ZH^EVFB3Z>D6S8[W0D#* K Y'??\
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M+=\-6]X>\0MJ-_<VEQ%.DS-(Z%\; $*JR#!R-NY<Y'))Q0!B_&3_ ))S<_\
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MM+>SB2!V#.F,[B,8)SUZ#\JDATRRMKZ>]AM8TN9P!+*JX+8]:M44 <#\9/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG_).;G_K[M?_ $<E=]7FWQHU2PA\%MILMY E]<7%N\-NS@/(HF3) [XKTF@
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MJ;F8*%,CG<[#W;J:GH 9%#'!&(X8UCC7HJ# 'X4^BB@ HHHH **** "BBB@
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M@%F+$_4GDUP_]@?$G_H=]._\%*__ !5']@?$G_H=]._\%*__ !5 '?45P/\
M8'Q)_P"AWT[_ ,%*_P#Q5']@?$G_ *'?3O\ P4K_ /%4 =]17F&HV'Q4L[W3
MH;?Q+9W<=U,8YI4TM0+=<$[VYY':M'^P/B3_ -#OIW_@I7_XJ@#OJ*X'^P/B
M3_T.^G?^"E?_ (JC^P/B3_T.^G?^"E?_ (J@#OJ*X'^P/B3_ -#OIW_@I7_X
MJC^P/B3_ -#OIW_@I7_XJ@#OJ*\PBL/BH_B"?3V\2V:6D<"RI?'2UV2,204
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M']@?$G_H=]._\%*__%4 =]17 _V!\2?^AWT[_P %*_\ Q5']@?$G_H=]._\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
2HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %" F8# 2(  A$! Q$!_\0
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M =+_ / ./_"M>B@#(_X17P[_ - '2_\ P#C_ ,*/^$5\._\ 0!TO_P  X_\
M"M>B@#(_X17P[_T =+_\ X_\*/\ A%?#O_0!TO\ \ X_\*UZ* ,C_A%?#O\
MT =+_P# ./\ PH_X17P[_P! '2__  #C_P *UZ* ,C_A%?#O_0!TO_P#C_PH
M_P"$5\._] '2_P#P#C_PK7HH R/^$5\._P#0!TO_ , X_P#"C_A%?#O_ $ =
M+_\  ./_  K7HH R/^$5\._] '2__ ./_"C_ (17P[_T =+_ / ./_"M>B@#
M(_X17P[_ - '2_\ P#C_ ,*/^$5\._\ 0!TO_P  X_\ "M>B@#(_X17P[_T
M=+_\ X_\*/\ A%?#O_0!TO\ \ X_\*UZ* ,C_A%?#O\ T =+_P# ./\ PH_X
M17P[_P! '2__  #C_P *UZ* ,C_A%?#O_0!TO_P#C_PH_P"$5\._] '2_P#P
M#C_PK7HH R/^$5\._P#0!TO_ , X_P#"C_A%?#O_ $ =+_\  ./_  K7HH R
M/^$5\._] '2__ ./_"C_ (17P[_T =+_ / ./_"M>B@#(_X17P[_ - '2_\
MP#C_ ,*/^$5\._\ 0!TO_P  X_\ "M>B@#(_X17P[_T =+_\ X_\*/\ A%?#
MO_0!TO\ \ X_\*UZ* ,C_A%?#O\ T =+_P# ./\ PH_X17P[_P! '2__  #C
M_P *UZ* ,C_A%?#O_0!TO_P#C_PH_P"$5\._] '2_P#P#C_PK7HH R/^$5\.
M_P#0!TO_ , X_P#"C_A%?#O_ $ =+_\  ./_  K7HH R/^$5\._] '2__ ./
M_"C_ (17P[_T =+_ / ./_"M>B@#(_X17P[_ - '2_\ P#C_ ,*/^$5\._\
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MY/)/3/:KU !1110 4444 %%%% !1110 4444 %%%% !1110!YW\9?^10M/\
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MM1110 4444 >=_&7_D4+3_K_ $_]%R44?&7_ )%"T_Z_T_\ 1<E% '6^%?\
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M0 Z!L_49IVTN*^MBG_94N<_VM?\ _?2>N?[GX?2D_LR12N=7O^HP"T?/)/\
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M=Y-9V]Q/!/+$KRP%C$Q_A)!4_H2*HP^&M'@M[B".PC\JX4)(K$ME020HR?E
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MVEE..^"7./RKT6QNA=^*)Y!#/%_H,?RS1E#]]ST-;M9*?\C;/_UXQ_\ HQZ
M-:BBB@ HHHH \[^,O_(H6G_7^G_HN2BCXR_\BA:?]?Z?^BY** .M\*_\BAHG
M_7A!_P"BUK7K(\*_\BAHG_7A!_Z+6M>@#SSQ/X+N+_7[C48_#'AC5TGV_->[
MX9U( 'S, P8<>@KJ_#MOJ]O8>7JL>FP;<+!;:>K".% /NY;&?P '%<Q\2IO$
M4,^B-HLMP;<3EKBWM)XXII0I5CC>1E0@DR!WP3Q72^$9-0F\):9+JEPEQ>/
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M<]+@]SG_ .M]* -*BLW^QQG/]H:A_P"!!]<__6^E T< C_B8:@<8ZW!['/\
M6@#2HK,71@N/^)CJ)QCK<'G&?\?T% T8 #_B8ZB<8ZW![#'_ -?ZT :=%9G]
MC#&/[1U'_P "#Z8_^O\ 6@Z,"#_Q,=1&<]+@]QC^F?K0!IT5F'1@<_\ $QU$
M9STN#QG'^'ZFE.C D_\ $PU 9STN#W.?Z8^E &E16;_8XSG^T-0_\"#ZY_\
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MM242NEI;F(+)"K1L^\R< ;A'TY.2.AKI? :V*^!])&FO,]KY.5:90K[MQW9
MX!W;N!QZ4 =%17&:Q=ZI;^(7:QOYKF2$^=-:H@$$%N(SP_<R,W(YS[  YRVU
MG5;2VMXUU*>;^T+"TN))GVDP/+,J,4XX!#G Y VT >CUS>L0K/XTT&-FD -M
M><HY4_\ +'N.:G\.7%PTNK6<\\EPEE>F&*60@L5,:/@GN06(S]*S=2U%_P#A
M.](']G7O[JWO "$7$G,7*_-TX[XZBFG8&KF_;Z=)#>%WN&EMUYAC?+,A.,DL
M3STX],FM"LTZM)C/]DZA_P!\)Z9_O?A]:#JT@S_Q*=0.,]$3G !_O>_Z4-M[
MB2L:5%9IU:09_P")5J!QGHB<XQ_M>_Z4'5I 3_Q*M0/_  !/7'][\?I2&:5%
M9O\ :LF?^05J'_?">N/[WX_2@:M(<?\ $JU 9QU1.,DC^][?K0!I45FC5I#C
M_B4Z@,XZHG&<_P"U[?K0-6D('_$IU =/X$],_P![\/K0!I45F_VM)C/]DZA_
MWPGIG^]^'UH.K2#/_$IU XST1.< '^][_I0!I45FG5I!G_B5:@<9Z(G.,?[7
MO^E!U:0$_P#$JU XS_ GKC^]^/TH TJ*S?[5DSC^RM0_[X3UQ_>_'Z4#5I#C
M_B5:@,XZHG&21_>]OUH TJ*S1JTAQ_Q*=0&<=43C.?\ :[8_6@:M(0/^)3J
MSC^!/3/][\/K0!I45F_VM)C/]DZA_P!\)Z9_O?A]:#JT@S_Q*=0.,]$3G !_
MO>^/PH TJ*S3JT@S_P 2K4#C/1$YQC_:]_TH.K2 G_B5:@<9_@3UQ_>_'Z4
M:5%9O]JR9Q_96H?]\)ZX_O?C]*!JTAQ_Q*M0&<=43C)(_O>V?QH TJ*S1JTA
MQ_Q*=0&<=43C.?\ :[8_6@:M(0/^)3J SC^!/3/][\/K0!I45F_VM)C/]DZA
M_P!\)Z9_O?A]:#JT@S_Q*=0.,]$3G !_O>^/PH TJ*S3JT@S_P 2K4#C/1$Y
MQC_:[Y_2@ZM("?\ B5:@<9Z(GKC^]^/TH TJ*S?[5DSC^RM0_P"^$]<?WOQ^
ME U:0X_XE6H#..J)QDX_O>V?QH TJ*S1JTAQ_P 2K4!G'5$XSG_:[8_44#5I
M"!_Q*=0&<?P)Z9_O?A]: -*BLW^UI,?\@G4/^^$],_WOP^M!U:09_P")3J!Q
MGHB<X&?[WX?A0!I45FG5I!G_ (E6H'&>B)SC'^UWS^AH.K2 G_B5:@<9Z(G/
M./[WX_2@#2HK-_M63./[*U#_ +X3UQ_>_'Z4#5I#C_B5:@,XZHG&3C^]^- &
ME16:-6D./^)5J SCJB<9S_M=L?J*!JTA _XE.H#..J)Z9_O?A]: -*BLW^UI
M,9_LG4/^^$],_P![\/K0=6D&?^)3J!QGHB<\9_O?A0!I45FG5I!G_B5:@<9Z
M(G.,?[7?/Z&@ZM("?^)5J!QGHB<\X_O?C0!I45F_VK)G']E:A_WPGKC^]^/T
MH&K2$C_B5:@,XZHG'./[WX_2@#2HK-&K2''_ !*M0&<=43C.?]KMC]10-6D.
M/^)3J SCJB<<9_O?A0!I45F_VM)C/]DZA_WPGIG^]^'UH.K2 '_B4Z@<9Z(G
MIG^]^'UH TJ*S3JT@S_Q*M0.,]$3G&/]KOG]#0=6D&?^)5J!QGHB<X./[WX_
MA0!I45F_VK)G']E:A_WPGKC^]^/TH&K2$C_B5:@,XZHGKC^]^/TH TJ*S1JT
MAQ_Q*M0&<=43C.?]KMC]10-6D./^)3J SCJB<9!/][VQ^- &E16;_:TF,_V3
MJ'_?">F?[WX?6@ZM( ?^)3J!QGHB>F?[WX?6@#2HK-.K2#/_ !*M0.,]$3G&
M/]KOG]#0=6D&?^)5J!QGHB<X('][WS^% &E16;_:LF<?V5J'_?">N/[WX_2@
M:M(2/^)5J SC^!/7'][\?I0!I5DI_P C;/\ ]>,?_HQZD&K2''_$JU 9QU1.
M,Y_VNV/UJI8W+77BB=VMI[<_88_EF !^^_H30!NT444 %%%% 'G?QE_Y%"T_
MZ_T_]%R44?&7_D4+3_K_ $_]%R44 =;X5_Y%#1/^O"#_ -%K6O61X5_Y%#1/
M^O"#_P!%K6O0!YEXQL[_ ,3:W?V,-UHKQZ2BSD/#="XMU=.1YD3#)8 _*.2,
M<5V/@UH7\':4UL]FT!MU\LV2,D6WMM5OF''7/.<YK.O_  WKT&LWU_X<UJUL
MEU$JUS%=69F D50@="&7!VA1@Y'%;>@:-#X?T*TTJ"1Y$MTV^8_5V))9CCU)
M)_&@ 70-+347U!;-%NI'\QY%)&YL8R1G!. !^%$/A_2+>"Y@BTZW6*Y&)DV<
M..>/IR<#H,UI44 5[*QM=.MA;V<"0Q EMJCJ3R2?4^]8^I?\CSH'_7K>?^T:
MZ"N?U+_D>= _Z];S_P!HT =!1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5DI_P C;/\ ]>,?_HQZUJR4_P"1MG_Z\8__ $8] &M1110 4444
M >=_&7_D4+3_ *_T_P#1<E%'QE_Y%"T_Z_T_]%R44 =;X5_Y%#1/^O"#_P!%
MK6O61X5_Y%#1/^O"#_T6M:] !1110 45FS:]IT&M)I#W %ZT#7!0#[D:XR6/
M0=>_O5*+QAI<EM-.PN(E2))D62(AIHW;:C(.^XX [\C.,T ;]<_J7_(\Z!_U
MZWG_ +1K3TW4X-4AD>%9(WAD,4L4J[7C<8."/H0?H169J7_(\Z!_UZWG_M&@
M#H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LE/^1MG_ .O&
M/_T8]:U9*?\ (VS_ /7C'_Z,>@#6HHHH **** /._C+_ ,BA:?\ 7^G_ *+D
MHH^,O_(H6G_7^G_HN2B@#K?"O_(H:)_UX0?^BUK7K(\*_P#(H:)_UX0?^BUK
M7H **** ,35M%EU+5K68,B0+:W,$IS\V9 @!'K]TU@'PIJUS!$\XM8KBQM+>
MVMPLI99FBE60LW VAM@&.2,FNZHH Q]"T^YM&U&[O%CCN+ZZ\\Q1ON$8"*@&
M<#)PF3QWK*U+2XCXZT<^?>?OK>\9O]*DPO,7W>?E'/08[>E=;7/ZE_R/.@?]
M>MY_[1H O_V- 1C[3?\ _@9+Z8_O?Y/-!T: Y_TF_P"<]+R7N /[WM6C10!G
MG1X#G_2;_G/2\E[X_P!KVH.CP$D_:;_G_I\D]<_WO\CBM"B@#/\ ['@SG[3?
M?^!DOKG^]_D<4#1X!C_2;_C'6\E[$G^][UH44 9PT: 8_P!)O^,=;R7MG_:]
MZ!HT  _TF_X_Z?)?3'][_)YK1HH SO[&@QC[3?\ _@9+Z8_O?Y/-!T: Y_TF
M_P"<]+R7N /[WM6C10!G'1X#G_2;_G/2\E[X_P!KVI3H\!)_TF_YS_R^2>N?
M[W^1Q6A10!G_ -CP9S]IOO\ P,D]<_WO\CB@:/ ,?Z3?\8ZWDO8D_P![WK0H
MH SAHT Q_I-_QCK>2]L_[7O0-&@  ^TW_&/^7R7TQ_>_R>:T:* ,[^QH,8^T
MW_\ X&2^F/[W^3S0=&@.?])O^<]+R7N,?WO:M&B@#..C0'/^DW_.>EY+WQ_M
M>U*='@)/^DW_ #G_ )?)?7/][_(XK0HH S_['@SG[3?_ /@9)ZY_O?Y'% T>
M 8_TF_XQUO)>QS_>]ZT** ,X:- ,?Z3?\8ZWDO;/^U[T#1H !_I-_P 8_P"7
MR7TQ_>_R>:T:* ,[^QH,8^TW_P#X&2^F/[W^3S0=&@.?])O^<]+R7N,?WO:M
M&B@#..C0-G_2;_G/2\E[X_VO:E.CP$G_ $F_YS_R^2^N?[W^1Q6A10!G_P!C
MP9S]IOO_  ,D]<_WO\CB@:/ ,?Z3?\8ZWDO8Y_O>]:%% &<-&@7'^DW_ !CK
M>2]L_P"U[T#1H!C_ $F_XQ_R^2^F/[U:-% &=_8T&,?:;_\ \#)?3'][_)YH
M.C0'/^DW_.>EY+W&/[WM6C10!G'1X&S_ *3?\YZ7DHZX_P!KVI3H\!)_TF_Y
MSTO).YS_ 'JT** ,_P#L>#.?M-]_X&2>N?[W^1Q0-'@&/])O^,=;R7L<_P![
MWK0HH SAHT"X_P!)O^,=;R4],_[7O0-&@ '^DW_&/^7R7L,?WJT:* ,[^QH,
M8^TW_P#X&2^F/[W^3S0=&@.?])O^<]+R7N,?WO:M&B@#..C0'/\ I-_SGI>2
M]\?[7M2G1X"3_I-_SGI>2]SG^][5H44 9_\ 8\&<_:;[_P #)/7/][_(XH&C
MP C_ $F_XQUO)>QS_>]ZT** ,X:- N/])O\ C'6\E/3/^U[T#1H!C_2;_C'6
M\E[#'][WK1HH SO[&@QC[3?_ /@9+Z8_O?Y/-!T: @_Z3?\ .?\ E\E[C']Z
MM&B@#..C0-G_ $F_YSTO)1UQ_M>U*='@.?\ 2;_G/2\E[G/][VK0HH S_P"Q
MX,Y^TWW_ (&2>N?[W^1Q0-'@!'^DW_&/^7R7US_>K0HH SAHT Q_I-_QCK>2
M]L_[7O0-&@&/])O^,=;R7L,?WO>M&B@#._L:#&/M-_\ ^!DOIC^]_D\T'1H"
M#_I-_P Y_P"7R7TQ_>_R>:T:* ,XZ- V?])O^<]+R4=<?[7M2G1X#G_2;_G/
M2\E[G/\ >]JT** ,_P#L>#.?M-]_X&2>N?[W^1Q0-'@!'^DW_&/^7R7US_>_
MR.*T** ,X:/ ,?Z3?\8ZWDO;/^U[U4LK5+3Q3/&DDSC[#'S+*TA^^XZL2:W*
MR4_Y&V?_ *\8_P#T8] &M1110 4444 >=_&7_D4+3_K_ $_]%R44?&7_ )%"
MT_Z_T_\ 1<E% '6^%?\ D4-$_P"O"#_T6M:]9'A7_D4-$_Z\(/\ T6M:] !1
M110 4444 %<_J7_(\Z!_UZWG_M&N@KG]2_Y'G0/^O6\_]HT =!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5DI_R-L__ %XQ_P#HQZUJR4_Y
M&V?_ *\8_P#T8] &M1110 4444 >=_&7_D4+3_K_ $_]%R44?&7_ )%"T_Z_
MT_\ 1<E% '6^%?\ D4-$_P"O"#_T6M:]9'A7_D4-$_Z\(/\ T6M:] !1110
M5B>*[N>ST)GMY6A:2>&%I5X,:/(JLP/8X)Y[5MU'-!%<P/!/&DL4BE71QD,#
MV(H Q?#<T[2ZQ:23R3PV=\88))7WMM,:,5+=3AF(YYK,UG4;N#QGI,J:'J,Z
M06]V/W/E$N"8AN +CCZX/(KJK6SMK"W6"T@C@A7)"1J% SR>!3;6>SU"*&_M
M9(;B-E(CGC(8%2>0#]5&?I0!D?\ "377_0KZ[_WQ#_\ ':/^$FNO^A7UW_OB
M'_X[7044 <__ ,)-=?\ 0KZ[_P!\0_\ QVC_ (2:Z_Z%?7?^^(?_ ([7044
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MU"PDBFCF&/.0<MM)&#WX.1@].: ,O_A)KK_H5]=_[XA_^.T?\)-=?]"OKO\
MWQ#_ /':Z"B@#G_^$FNO^A7UW_OB'_X[1_PDUU_T*^N_]\0__':Z"B@#G_\
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MUP6>[640Q2;85"#Y?*9>6C8$DD\G)!QC%=;%%'!$D42+'&@"JB# 4#H .PH
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M,_\ $0N 3WQWZU';^&--BUI-9=9I[Y;=(%DG?=C:"-^.F\@X+=:VJ "BBB@
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MJ-AI<6V*"-Y!&SH2Q>'Y2=\'W2H/(W,!@<5Z%10 U$2*-8XU5$4!551@ #H
M*=110 4444 87B:#4/LL=YIMZ(IH-P:VDD"1W*L,%"Q^Z_\ =;L>O!-<GX3\
M+)J%Q'JIA6/2I[?:D98'[9 0OEI+&5P"F&);DEF)!Q7H-[8VFI6K6M]:PW-N
M^-T4R!U..G!J9$6-%1%"HH 55& !Z"@!P  P.@HHHH **** *>JVMM>Z5=6]
MW9_;('C.^WP"9..@R1SZ<CGO7)>%?"JR1F^U**^0_:"\=O=. 9E7B.2= 2IE
M XW=3A2>:[FB@ HHHH **** .+\;I/9Q27LEVTVDRHJ7M@S@$*K ^9%Z]@R?
MQ*>.>J^$O"4^G/-<ZI'$LDCK+]FC<21>>,[KA05&QFS@!<84#/-=5=Z=8W[P
M/>6<%PT#^9"98PQC;U7/0U9H **** "BBB@##\5V5O>:(QEL[RXEA<20-8A?
M/A?LZ9(Y'ZC(((XJEX4\,)IUI9WEY&Z7PAYMO,W0VSM@OY2]$R1R!P.0.*ZF
MB@ HHHH **** ///%MMJ$6H):+=K>17LY:R29P3:W#(P"L,'=&1N*G!V,!U'
M3?\ "?AE-$L(_.B"RJ7\B(OYOV.-B/W*.1DKP">V>G&*VVTZR?4$U![.!KV-
M"B7!C!D53U ;J!5F@ HHHH **** .3\=:9]ML(I;73I[G4UW1V\D*(RC<.4F
M#$ PMT8<^O4 UJ:)X=M-%W21M/+.R+&'GF,IB0=(T)Y" D\?GFMBB@ HHHH
M**** /+]<TN]N=6CT.Y,>LL4?[,9IPIDM]RF6*0@'9(,H!(!\RDC@\UW'AW0
MQHNFPQS2FYO1$L<URX!=P,X4MC)"Y(&><5?BTZQ@OIKZ*SMX[N8!99UC =P.
M@+=35F@ HHHH **** .*\4Z"NH^(;$6NG7/F7#(+RXCPL+1*3RS9#+*G!1@,
M]LX)KIM)TBVT>V:*!I9))&WRSS-ODE;U9NYQQ]!5^B@ HHHH *@O;8WEE-;+
M/-;M(A430MAT)[J?45/10!Y3/HVH^(]7N+.8P3:A;F-I[Z*?8%XQ!<18!*D
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M5XB_Z#^J?^!DG^-%% !_PE7B+_H/ZI_X&2?XT?\ "5>(O^@_JG_@9)_C110
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)P3[FBBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Jun. 02, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000312070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">BARCLAYS BANK PLC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-287303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Jun. 02, 2026 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Global Medium-Term Notes, Series A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 986,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 136.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), was originally deferred in accordance with Rule 456(b) under the Securities Act.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Jun. 02, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 986,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">136.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">136.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 986,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>26</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp247733_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dp247733_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dp247733_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="dp247733_exfilingfees.htm">dp247733_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp247733_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "dp247733_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 26,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/ffd/2025": 6,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 24,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp247733_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp247733_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp247733_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp247733_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp247733_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp247733_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0000950103-26-008330-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-26-008330-xbrl.zip
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M_P-02P$"% ,4    "  EH\)<7 %#-[$*  !]-P  &0              @ $
M    9' R-#<W,S-?97AF:6QI;F=F965S+FAT;5!+!08      0 ! $<   #H
%"@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>dp247733_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000312070</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-06-02</startDate>
            <endDate>2026-06-02</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000312070</identifier>
        </entity>
        <period>
            <startDate>2026-06-02</startDate>
            <endDate>2026-06-02</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="fee_001">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="fee_002">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="fee_003">0000312070</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="fee_004">333-287303</ffd:RegnFileNb>
    <ffd:OfferingTableNa contextRef="c_report" id="fee_005" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="c_report" id="fee_006">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="c_report" id="fee_007">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FormTp contextRef="c_report" id="fee_008">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="fee_009">BARCLAYS BANK PLC</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="fee_010">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="fee_011">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="fee_012">Global Medium-Term Notes, Series A</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="c_offering_1" id="fee_013">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="fee_014"
      unitRef="shares">986</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_015"
      unitRef="USD">1000</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_016"
      unitRef="USD">986000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_017"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-223"
      unitRef="USD">136.17</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-224"
      unitRef="USD">986000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-225"
      unitRef="USD">136.17</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-226"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-227"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-228"
      unitRef="USD">136.17</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="ixv-229">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), was originally deferred in accordance with Rule 456(b) under the Securities Act.</ffd:OfferingNote>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="c_report"
      decimals="INF"
      id="ixv-230"
      unitRef="USD">986000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c_report" id="ixv-231">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
